Existential	O
phenomenology	O
and	O
the	O
sociological	O
tradition	O
.	O
Dual	O
leadership	O
in	O
complex	O
organizations	O
.	O
Scientists	O
at	O
major	O
and	O
minor	O
universities	O
:	O
a	O
study	O
of	O
productivity	O
and	O
recognition	O
.	O
Demotion	O
in	O
industrial	O
management	O
.	O
Career	O
anchorage	O
:	O
managerial	O
mobility	O
motivations	O
.	O
Social	O
class	O
and	O
premarital	O
sexual	O
permissiveness	O
:	O
a	O
re-examination	O
.	O
A	O
comment	O
on	O
``	O
anomy	O
''	O
.	O
A	O
factor	O
analytic	O
exploration	O
of	O
the	O
alienation	O
,	O
anomia	O
and	O
authoritarianism	O
domain	O
.	O
Technical	O
note	O
on	O
two	O
rates	O
of	O
mixed	O
marriage	O
.	O
Some	O
comments	O
on	O
awareness	O
.	O
On	O
experimental	O
design	O
.	O
Observations	O
on	O
the	O
incidence	O
of	O
following	O
of	O
visual	O
and	O
auditory	O
stimuli	O
in	O
naive	O
mallard	O
ducklings	O
(	O
Anas	O
platyrhynchos	O
)	O
.	O
The	O
comfort	O
movements	O
of	O
Anatidae	O
.	O
Potential	O
ethological	O
isolating	O
mechanisms	O
and	O
assortative	O
mating	O
in	O
the	O
domestic	O
fowl	O
.	O
An	O
experimental	O
study	O
of	O
conflict	O
and	O
fear	O
:	O
an	O
analysis	O
of	O
behavior	O
of	O
young	O
chicks	O
toward	O
a	O
mealworm	O
.	O
I	O
.	O
The	O
behavior	O
of	O
chicks	O
which	O
do	O
not	O
eat	O
the	O
mealworm	O
.	O
The	O
measuring	O
function	O
of	O
the	O
first	O
legs	O
of	O
Araneus	O
diadematus	O
Cl	O
.	O
The	O
transport	O
of	O
prey	O
by	O
ants	O
.	O
Courtship	O
behaviour	O
in	O
the	O
Drosophila	O
obscura	O
group	O
.	O
II	O
.	O
Comparative	O
studies	O
.	O
Vision	O
versus	O
touch	O
in	O
form	O
discrimination	O
.	O
Short-term	O
retention	O
as	O
a	O
function	O
of	O
method	O
of	O
measurement	O
,	O
recording	O
time	O
,	O
and	O
meaningfulness	O
of	O
the	O
material	O
.	O
The	O
conservation	O
of	O
a	O
shape	O
property	O
and	O
a	O
proposal	O
about	O
the	O
origin	O
of	O
the	O
conservations	O
.	O
Persisting	O
odours	O
as	O
a	O
biasing	O
factor	O
in	O
open-field	O
research	O
with	O
mice	O
.	O
The	O
display	O
of	O
information	O
and	O
the	O
judgment	O
of	O
contingency	O
.	O
Vividness	O
of	O
words	O
and	O
learning	O
to	O
learn	O
in	O
free-recall	O
learning	O
.	O
[	O
Genetic	O
study	O
of	O
the	O
memorization	O
of	O
words	O
and	O
pictures	O
]	O
Amylase	O
production	O
by	O
Streptomyces	O
species	O
.	O
Physico-chemical	O
studies	O
on	O
the	O
stability	O
of	O
penicillin	SYMP
salts	SYMP
.	O
IV	O
.	O
A	O
statistical	O
evaluation	O
.	O
Studies	O
on	O
nitrogen	O
metabolism	O
of	O
Penicillium	O
chrysogenum	O
Thom	O
.	O
I	O
.	O
Effects	O
of	O
lactose	O
and	O
sucrose	O
additions	O
on	O
nitrogen	O
metabolism	O
.	O
Studies	O
on	O
nitrogen	O
metabolism	O
of	O
Penicillium	O
chrysogenum	O
Thom	O
.	O
II	O
.	O
Amino	O
acid	O
metabolism	O
and	O
its	O
relation	O
to	O
the	O
biosynthesis	O
of	O
penicillin	SYMP
.	O
The	O
contribution	O
of	O
thoracic	SYMP
surgery	SYMP
to	O
our	O
discipline	O
.	O
Research	O
past	O
and	O
present	O
,	O
with	O
particular	O
reference	O
to	O
the	O
application	O
of	O
the	O
techniques	O
of	O
basic	O
science	O
to	O
the	O
problems	O
of	O
adrenal	O
pathology	O
.	O
Some	O
inflammatory	SYMP
disorders	SYMP
of	O
the	O
large	O
intestine	O
.	O
Coexistence	O
of	O
subdural	O
and	O
archnoidal	O
collections	O
of	O
fluid	O
:	O
an	O
unusual	O
case	O
.	O
The	O
scope	O
of	O
sphincterotomy	SYMP
in	O
biliary	SYMP
and	SYMP
pancreatic	SYMP
surgery	SYMP
.	O
Sarcoidosis	SYMP
involving	O
the	O
veriform	O
appendix	O
.	O
``	O
Chronic	SYMP
pancreatitis	SYMP
''	O
and	O
carcinoma	SYMP
of	SYMP
the	SYMP
pancreas	SYMP
.	O
A	O
method	O
to	O
aid	O
correct	O
diagnosis	O
.	O
YES	O
[	O
Diagnosis	O
and	O
therapy	O
of	O
chronic	SYMP
aspecific	SYMP
pancreatitis	SYMP
]	O
YES	O
[	O
Further	O
data	O
on	O
mediastinal	SYMP
and	SYMP
pulmonary	SYMP
tumors	SYMP
of	O
the	O
child	O
.	O
Review	O
and	O
personal	O
cases	O
]	O
[	O
Dextran	O
of	O
low	O
molecular	O
weight	O
in	O
peripheral	SYMP
arterial	SYMP
insufficiency	SYMP
]	O
[	O
Clinico-statistical	O
considerations	O
on	O
vescicular	SYMP
mole	SYMP
]	O
[	O
On	O
the	O
significance	O
of	O
histologic	O
findings	O
in	O
neoplasms	SYMP
of	O
the	O
trophoblast	O
(	O
case	O
contributions	O
)	O
]	O
Diagnostic	O
evaluation	O
of	O
the	O
patient	O
with	O
high	SYMP
blood	SYMP
pressure	SYMP
.	O
Epidemiology	O
of	O
hypertension	SYMP
.	O
Renal	SYMP
vascular	SYMP
hypertension	SYMP
;	O
diagnosis	O
and	O
treatment	O
.	O
The	O
use	O
of	O
radioactive	O
isotopes	O
in	O
the	O
diagnosis	O
of	O
hypertension	SYMP
.	O
The	O
angiogram	O
in	O
the	O
study	O
of	O
hypertension	SYMP
.	O
Guanethidine	O
.	O
Hepatocerebral	SYMP
degeneration	SYMP
(	SYMP
portal	SYMP
systemic	SYMP
encephalopathy	SYMP
)	SYMP
.	O
The	O
relationship	O
to	O
fatty	O
acids	O
.	O
[	O
Oviposition	O
and	O
its	O
regulation	O
in	O
the	O
polygynous	O
society	O
of	O
Polistes	O
gallicus	O
L	O
.	O
]	O
Interaction	O
of	O
aggressive	O
and	O
sexual	O
behavior	O
in	O
male	O
mice	O
.	O
Conflict	O
and	O
conditioned	O
aversive	O
stimuli	O
in	O
the	O
development	O
of	O
experimental	O
neuroses	O
.	O
Study	O
of	O
the	O
effect	O
of	O
newer	O
analeptic	O
(	O
Micoren	O
)	O
in	O
hypoventilation	O
syndrome	O
.	O
Treatment	O
of	O
a	SYMP
disorder	SYMP
of	SYMP
perception	SYMP
and	SYMP
concept	SYMP
formation	SYMP
in	O
a	O
case	O
of	O
school	O
failure	O
.	O
Rorschach	O
correlates	O
of	O
time	O
estimation	O
.	O
Use	O
of	O
food	O
in	O
child	SYMP
psychotherapy	SYMP
.	O
[	O
About	O
genital	O
discharge	O
with	O
special	O
consideration	O
of	O
its	O
cervical	O
manifestation	O
]	O
[	O
Auto-uro	SYMP
therapy	SYMP
:	O
status	O
and	O
future	O
prospects	O
]	O
[	O
Clinical	O
experience	O
with	O
the	O
surface	SYMP
anesthetic	SYMP
xylocaine	SYMP
in	O
obstetrics	O
]	O
[	O
The	O
problem	O
of	O
medicinal	O
management	O
of	O
labor	O
]	O
[	O
Conglutination	O
of	O
the	O
labia	O
minora	O
]	O
[	O
The	O
fight	O
against	O
hemolytic	SYMP
disease	SYMP
of	O
the	O
newborn	O
in	O
general	O
practice	O
]	O
YES	O
[	O
On	O
socalled	O
nervous	O
exhaustion	O
]	O
[	O
Examination	O
of	O
neonatal	O
archaic	O
(	O
primitive	O
)	O
reflexes	O
in	O
icterus	SYMP
gravis	SYMP
]	O
[	O
Urologic	O
complications	O
in	O
non-recurrent	SYMP
cancer	SYMP
of	O
the	O
cervix	O
]	O
YES	O
The	O
complexing	O
of	O
calcium	O
by	O
citrate	O
,	O
ortho-	O
and	O
polyphosphates	O
.	O
A	O
method	O
of	O
determining	O
the	O
patency	O
of	O
the	O
nasolacrimal	O
apparatus	O
.	O
Intra-arterial	O
infusion	O
of	O
the	O
head	O
and	O
neck	O
.	O
Anatomic	O
and	O
distributional	O
problems	O
.	O
Lymphatics	O
of	O
the	O
mouth	O
and	O
neck	O
.	O
[	O
Effect	O
of	O
sodium	O
ions	O
on	O
the	O
behavior	O
of	O
rest	O
and	O
action	O
potentials	O
of	O
the	O
cell	O
membrane	O
of	O
the	O
rat	O
myometrium	O
]	O
[	O
Studies	O
on	O
contractile	O
properties	O
of	O
the	O
blood	O
serum	O
]	O
[	O
Twin	O
pregnancy	O
and	O
fetal	O
and	O
infantile	O
perinatal	SYMP
mortality	SYMP
]	O
[	O
Fate	O
of	O
the	O
2d	O
twin	O
]	O
[	O
Differential	O
diagnosis	O
of	O
infectious	SYMP
hepatitis	SYMP
in	O
pregnancy	O
]	O
[	O
Epithelial	O
metaplasia	SYMP
of	O
the	O
endometrium	O
]	O
[	O
Leukoplakia	SYMP
of	O
the	O
vaginal	O
portion	O
of	O
the	O
uterus	O
and	O
its	O
clinical	O
evaluation	O
]	O
[	O
Blood	O
loss	O
in	O
artificial	O
interruption	O
of	O
pregnancy	O
]	O
[	O
Modified	SYMP
bra	SYMP
in	O
the	O
prevention	O
of	O
mastitis	SYMP
in	O
nursing	O
mothers	O
]	O
[	O
Hormonal	O
phenomenon	O
after	O
the	O
excision	O
of	O
hydatiform	O
mole	O
]	O
[	O
Fetal	O
chondrodystrophy	O
]	O
[	O
Malignant	SYMP
mesodermal	SYMP
mixed	SYMP
tumor	SYMP
of	O
the	O
uterus	O
following	O
irradiation	SYMP
]	O
Supportive	O
role	O
of	O
nurse	O
in	O
first	O
stage	O
of	O
labor	O
``	O
can	O
not	O
be	O
emphasized	O
enough	O
''	O
,	O
according	O
to	O
patient	O
.	O
Toxemia	SYMP
of	O
pregnancy	O
.	O
Outpatient	O
care	O
--	O
the	O
role	O
of	O
the	O
nurse	O
.	O
Abandonment	O
:	O
deepest	O
fear	O
of	O
hospitalized	O
children	O
.	O
Support	O
in	O
first	O
stage	O
of	O
labor	O
.	O
The	O
family	O
physician	O
and	O
cervical	SYMP
carcinoma	SYMP
--	O
challenge	O
and	O
opportunity	O
.	O
[	O
Purposeful	O
``	O
heroic	O
''	O
heart	O
treatment	O
]	O
Skilled	O
workers	O
are	O
vital	O
to	O
maintenance	O
cost	O
cuts	O
.	O
Karen	O
:	O
the	O
other	O
side	O
of	O
the	O
picture	O
.	O
Rhesus	SYMP
haemolytic	SYMP
disease	SYMP
;	O
an	O
approach	O
to	O
prevention	O
.	O
Tumours	SYMP
of	O
the	O
uterus	O
.	O
2	O
.	O
Malignancy	O
.	O
Cancer	SYMP
of	O
the	O
vulva	O
.	O
Effects	O
of	O
smoking	O
on	O
selected	O
clinical	O
obstetric	O
factors	O
.	O
Amniotic	SYMP
fluid	SYMP
embolism	SYMP
.	O
A	O
review	O
of	O
the	O
syndrome	O
with	O
a	O
report	O
of	O
4	O
cases	O
.	O
Chronic	SYMP
histiocytosis	SYMP
X	SYMP
associated	O
with	O
pregnancy	O
.	O
Disseminated	SYMP
lupus	SYMP
erythematosus	SYMP
in	O
pregnancy	O
.	O
Intralesional	SYMP
therapy	SYMP
with	SYMP
betamethasone	SYMP
.	O
[	O
Strucutre	O
of	O
the	O
influenza	SYMP
virus	SYMP
]	O
2	O
students	O
at	O
Quo	O
Vadis	O
.	O
Double	O
aortic	O
arch	O
associated	O
with	O
tetralogy	O
of	O
Fallot	O
in	O
infants	O
;	O
report	O
of	O
two	O
cases	O
.	O
Tested	O
questionnaires	O
help	O
administration	O
learn	O
if	O
programs	O
are	O
a	O
success	O
,	O
and	O
why	O
.	O
Dumping	SYMP
syndrome	SYMP
following	O
pyloroplasty	SYMP
.	O
Measured	O
subtotal	O
gastrectomy	O
for	O
duodenal	O
ulcer	O
.	O
The	O
lesions	O
in	O
bovine	O
udders	O
shedding	O
nonhemolytic	O
coagulase-negative	O
staphylococci	O
.	O
Repository	O
vitamin	O
B	O
12	O
preparations	O
.	O
Mass	O
spectrometry	O
in	O
structural	O
and	O
stereochemical	O
problems	O
.	O
93	O
.	O
Further	O
observations	O
on	O
the	O
importance	O
of	O
interatomic	O
distance	O
in	O
the	O
McLafferty	O
rearrangement	O
.	O
Synthesis	O
and	O
fragmentation	O
behavior	O
of	O
deuterium-labeled	O
12-keto	O
steroids	O
.	O
Treatment	O
of	O
childhood	SYMP
schizophrenia	SYMP
.	O
A	O
three-year	O
comparison	O
of	O
day	O
and	O
residental	O
treatment	O
.	O
Polycystic	O
ovaries	O
associated	O
with	O
congenital	SYMP
adrenal	SYMP
hyperplasia	SYMP
.	O
Beta-propiolactone	SYMP
as	O
used	O
in	O
sterilization	O
of	O
homografts	O
not	O
carcinogenic	O
for	O
mice	O
.	O
New	O
operations	O
in	O
children	O
's	O
cardiac	O
disease	O
.	O
Effect	O
of	O
diabetes	SYMP
and	O
starvation	O
on	O
myocardial	O
triglyceride	O
and	O
free	O
fatty	O
acid	O
utilization	O
.	O
Effect	O
of	O
epinephrine	O
on	O
myocardial	O
triglyceride	O
and	O
free	O
fatty	O
acid	O
utilization	O
.	O
Diurnal	O
periodicity	O
in	O
the	O
metabolic	O
activity	O
of	O
bone	O
tissue	O
.	O
Fine	O
structure	O
of	O
desmosomes	O
.	O
,	O
hemidesmosomes	O
,	O
and	O
an	O
adepidermal	O
globular	O
layer	O
in	O
developing	O
newt	O
epidermis	O
.	O
Redundant	O
myelin	O
sheaths	O
and	O
other	O
ultrastructural	O
features	O
of	O
the	O
toad	O
cerebellum	O
.	O
A	O
radioautographic	O
study	O
with	O
H3-thymidine	O
on	O
adrenal	O
medulla	O
nuclei	O
of	O
rats	O
intermittently	O
exposed	O
to	O
cold	O
.	O
A	O
fine	O
structural	O
analysis	O
of	O
the	O
epidermis	O
of	O
the	O
earthworm	O
,	O
Lumbricus	O
terrestris	O
L	O
.	O
Effect	O
of	O
thoracic	O
cava	O
obstruction	O
on	O
response	O
of	O
proximal	O
tubule	O
sodium	O
reabsorption	O
to	O
saline	O
infusion	O
.	O
The	O
metabolism	O
of	O
intravenously	O
injected	O
isotopic	O
cholic	O
acid	O
in	O
Laennec	SYMP
's	SYMP
cirrhosis	SYMP
.	O
The	O
origin	O
and	O
glyceride	O
distribution	O
of	O
fatty	O
acids	O
in	O
rat	O
adipose	O
tissue	O
.	O
Absorption	O
of	O
medium	O
and	O
long	O
chain	O
triglycerides	O
:	O
factors	O
influencing	O
their	O
hydrolysis	O
and	O
transport	O
.	O
The	O
effect	O
of	O
epinephrine	O
on	O
immunoreactive	O
insulin	O
levels	O
in	O
man	O
.	O
The	O
role	O
of	O
the	O
liver	O
in	O
serum-induced	O
hypercoagulability	SYMP
.	O
Comparative	O
fates	O
of	O
intravenously	O
and	O
orally	O
administered	O
aldosterone	O
:	O
evidence	O
for	O
extrahepatic	O
formation	O
of	O
acid-hydrolyzable	O
conjugate	O
in	O
man	O
.	O
Binding	O
of	O
sulfobromophthalein	O
(	O
BSP	O
)	O
sodium	O
by	O
plasma	O
albumin	O
.	O
Its	O
role	O
in	O
hepatic	O
BSP	O
extraction	O
.	O
YES	O
Etiology	O
and	O
incidence	O
of	O
renal	SYMP
stones	SYMP
.	O
Diagnosis	O
of	O
stone	SYMP
disease	SYMP
.	O
YES	O
YES	O
Prevention	O
of	O
stone	SYMP
formation	SYMP
.	O
Urinary	O
calculi	O
.	O
Is	O
the	O
task	O
hopeless	O
?	O
The	O
family	O
medicine	O
program	O
of	O
the	O
University	O
of	O
Miami	O
.	O
Electron	O
microscopic	O
studies	O
of	O
Mycoplasma	O
(	O
PPLO	O
strain	O
880	O
)	O
in	O
artificial	O
medium	O
and	O
in	O
tissue	O
culture	O
.	O
Chemotherapeutic	O
effects	O
on	O
mammalian	SYMP
tumor	SYMP
cells	SYMP
.	O
3	O
.	O
Modification	O
of	O
leukemia	O
L1210	O
growth	O
kinetics	O
with	O
an	O
antimetabolite	O
.	O
Comparison	O
of	O
the	O
sensitivity	O
of	O
normal	O
hematopoietic	O
and	O
transplanted	O
lymphoma	O
colony-forming	O
cells	O
of	O
mice	O
to	O
vinblastine	O
administered	O
in	O
vivo	O
.	O
Evidence	O
for	O
an	O
immunological	O
reaction	O
of	O
the	O
host	O
directed	O
against	O
its	O
own	O
actively	O
growing	O
primary	SYMP
tumor	SYMP
.	O
YES	O
Clinical	O
staging	O
in	O
cancer	SYMP
of	SYMP
the	SYMP
larynx	SYMP
:	O
a	O
report	O
on	O
788	O
cases	O
using	O
the	O
American	O
Joint	O
Committee	O
's	O
method	O
of	O
stage	O
classification	O
.	O
Comparison	O
of	O
the	O
international	O
and	O
American	O
systems	O
for	O
the	O
staging	O
of	O
breast	SYMP
cancer	SYMP
.	O
Effects	O
of	O
tryptophan	O
mustard	O
on	O
incorporation	O
of	O
amino	O
acids	O
into	O
proteins	O
in	O
tumor-bearing	O
rats	O
.	O
An	O
electron	O
microscope	O
study	O
of	O
plant	SYMP
neoplasia	SYMP
induced	O
by	O
wound	SYMP
tumor	SYMP
virus	SYMP
.	O
YES	O
[	O
The	O
postprandial	O
period	O
of	O
the	O
gastrectomized	O
patient	O
.	O
Radiocinematographic	O
and	O
clinical	O
correlation	O
]	O
[	O
Muscle	O
pathology	O
;	O
contribution	O
of	O
experimentation	O
]	O
Origin	O
of	O
milk	O
cholesterol	O
in	O
the	O
rat	O
:	O
dietary	O
versus	O
endogenous	O
sources	O
.	O
Comparative	O
effects	O
of	O
two	O
benzodiazepine	O
compounds	O
on	O
isolated	O
human	O
myometrium	O
.	O
Histochemistry	O
of	O
hydrolytic	O
and	O
oxidative	O
enzymes	O
in	O
the	O
human	O
and	O
experimentally	O
induced	O
adenocarcinoma	SYMP
of	O
the	O
endometrium	O
.	O
Cardiac	O
monitors	O
work	O
--	O
but	O
they	O
should	O
report	O
more	O
than	O
they	O
do	O
.	O
Delivery	O
room	O
pediatrics	O
.	O
The	O
responsibilities	O
of	O
the	O
obstetrician	O
.	O
A	O
pediatrician	O
's	O
checklist	O
for	O
adolescents	O
.	O
Community	O
clinic	O
treatment	O
for	O
back-ward	O
patients	O
.	O
Studies	O
in	O
infantile	SYMP
malnutrition	SYMP
.	O
V.	O
The	O
effect	O
of	O
dietary	O
protein	O
source	O
on	O
serum	O
proteins	O
.	O
YES	O
athyrism	SYMP
in	O
the	O
fetal	O
rat	O
.	O
Evidence	O
for	O
impairment	O
of	O
elastin	O
formation	O
.	O
Familial	SYMP
vitamin	SYMP
D	SYMP
resistant	SYMP
rickets	SYMP
in	O
untreated	O
adult	O
.	O
Bony	O
proliferation	O
of	O
neural	O
arches	O
with	O
cord	O
compression	O
.	O
Amyloidosis	SYMP
of	O
the	O
cornea	O
.	O
Report	O
of	O
a	O
case	O
without	O
conjunctival	O
involvement	O
.	O
Effect	O
of	O
tranquilizing	SYMP
drugs	SYMP
on	O
postnatal	O
behavior	O
.	O
Fathers	O
in	O
the	O
delivery	O
room	O
--	O
an	O
opposition	O
standpoint	O
.	O
Fathers	O
in	O
the	O
delivery	O
--	O
''	O
helpful	O
and	O
supportive	O
''	O
.	O
``	O
Return	O
the	O
joy	O
of	O
home	O
delivery	O
''	O
with	O
fathers	O
in	O
the	O
delivery	O
room	O
.	O
Fathers	O
in	O
the	O
delivery	O
room	O
--	O
long	O
experience	O
molds	O
one	O
viewpoint	O
.	O
Doctors	O
--	O
we	O
need	O
you	O
.	O
Pharmacological	O
blockade	O
of	O
ovulation	O
in	O
the	O
ewe	O
.	O
Some	O
factors	O
affecting	O
the	O
response	O
of	O
the	O
immature	O
mouse	O
to	O
pregnant	O
mare	O
serum	O
gonadotrophin	O
and	O
human	O
chorionic	O
gonadotrophin	O
.	O
The	O
metabolism	O
of	O
cortisol	O
by	O
human	O
extra-hepatic	O
tissues	O
.	O
Aromatization	O
of	O
7-alpha-hydroxydehydroepiandrosterone	O
and	O
of	O
its	O
3-sulphate	O
by	O
ovarian	O
and	O
placental	O
tissue	O
cultures	O
.	O
Metabolic	O
and	O
endocrine	O
effects	O
of	O
lysergic	O
acid	O
diethylamide	O
(	O
LSD-25	O
)	O
on	O
male	O
rats	O
.	O
Mutation	O
frequencies	O
detected	O
following	O
irradiation	SYMP
of	O
virgin	O
and	O
inseminated	O
Drosophila	O
melanogaster	O
females	O
.	O
Relationship	O
of	O
fractons	O
of	O
soybeans	O
and	O
a	O
crystalline	O
soybean	O
trypsin	O
inhibitor	O
to	O
the	O
effects	O
of	O
feeding	O
unheated	O
soybean	O
meal	O
to	O
chicks	O
.	O
Metabolism	O
of	O
polyunsaturated	O
fatty	O
acids	O
and	O
serum	O
cholesterol	O
levels	O
in	O
the	O
rat	O
.	O
Comparison	O
of	O
neutral	O
fat	O
and	O
free	O
fatty	O
acids	O
in	O
high	O
lipid-low	O
carbohydrate	O
diets	O
for	O
the	O
growing	O
chicken	O
.	O
An	O
approach	O
to	O
quantitative	O
analysis	O
of	O
intrauterine	O
pressure	O
data	O
.	O
Intracranial	SYMP
teratomas	SYMP
in	O
fetal	O
life	O
and	O
infancy	O
.	O
Twinning	O
in	O
relation	O
to	O
birth	O
weight	O
,	O
mortality	O
,	O
and	O
congenital	SYMP
anomalies	SYMP
.	O
Breast	O
engorgement	O
and	O
postpartum	SYMP
fever	SYMP
.	O
Evolution	O
of	O
a	O
placenta	O
circumvallata	O
.	O
Sequential	O
estrogen-progestogen	SYMP
therapy	SYMP
in	O
gynecology	O
.	O
Ovarian	SYMP
carcinoma	SYMP
.	O
The	O
problems	O
of	O
staging	O
and	O
grading	O
.	O
Oxytocin	O
induction	O
in	O
pregnant	O
rabbits	O
,	O
with	O
special	O
reference	O
to	O
the	O
stillbirth	O
rate	O
.	O
Significance	O
of	O
a	O
single	O
umbilical	O
artery	O
.	O
Report	O
from	O
the	O
collaborative	O
study	O
of	O
cerebral	O
palsy	O
.	O
Perforated	SYMP
peptic	SYMP
ulcer	SYMP
in	O
pregnancy	O
.	O
Poverty	O
as	O
an	O
isolated	O
factor	O
in	O
relation	O
to	O
perinatal	SYMP
asphyxia	SYMP
.	O
Perforation	SYMP
of	SYMP
the	SYMP
postpartum	SYMP
uterus	SYMP
with	O
an	O
intrauterine	O
contraceptive	O
device	O
.	O
Congenital	SYMP
heart	SYMP
disease	SYMP
,	O
deaf-mutism	SYMP
and	O
associated	SYMP
somatic	SYMP
malformations	SYMP
occurring	O
in	O
several	O
members	O
of	O
one	O
family	O
.	O
Toward	O
a	O
community	O
alcoholism	O
program	O
.	O
Cases	O
8	O
and	O
9	O
.	O
Anesthesia	SYMP
accidents	O
.	O
Gynaecological	O
pain	O
.	O
Profileplasty	SYMP
.	O
Hypertrophic	O
obstructive	O
cardiomyopathy	SYMP
.	O
Oral	SYMP
contraceptives	SYMP
,	O
thrombosis	SYMP
,	O
and	O
cyclical	O
factors	O
affecting	O
veins	O
.	O
[	O
On	O
the	O
influence	O
of	O
cytostatic	O
agents	O
and	O
immune	O
bodies	O
on	O
choriocarcinoma	O
cells	O
in	O
tissue	O
culture	O
]	O
Fat	O
absorption	O
:	O
a	O
transport	O
problem	O
.	O
Corpora	SYMP
lutea	SYMP
in	O
proven	O
mules	O
.	O
Reconstructive	O
tubal	SYMP
surgery	SYMP
.	O
[	O
Studies	O
on	O
the	O
natural	O
posterior	O
pituitary	O
hormones	O
.	O
II	O
]	O
[	O
On	O
the	O
official	O
inspection	O
of	O
coal-tar	O
dyes	O
in	O
1969	O
.	O
3	O
.	O
Analysis	O
of	O
Cr	O
,	O
Zn	O
,	O
Fe	O
and	O
Pb	O
contaminants	O
in	O
food	O
coal-tar	O
dyes	O
and	O
their	O
aluminium	O
lakes	O
by	O
atomic	O
absorption	O
spectrophotometry	O
]	O
[	O
Radiosterilization	O
of	O
medical	O
products	O
.	O
I	O
.	O
Effects	O
of	O
radiation	O
on	O
physical	O
and	O
chemical	O
properties	O
of	O
injection	O
needles	O
]	O
[	O
Screening	O
tests	O
of	O
microorganisms	O
for	O
the	O
microbial	O
transformation	O
of	O
griseophenone	O
A	O
,	O
N-methylcoclaurine	O
and	O
sparteine	O
]	O
[	O
Gas	O
chromatographic	O
studies	O
on	O
organic	O
mercurials	O
]	O
[	O
Application	O
of	O
infra-red	O
absorption	O
spectroscopy	O
to	O
examination	O
of	O
drugs	O
and	O
their	O
preparation	O
.	O
XIX	O
.	O
Determination	O
of	O
silicone	O
oil	O
in	O
disposable	O
plastic	O
syringes	O
]	O
[	O
Observation	O
of	O
air	O
pollution	O
with	O
the	O
aid	O
of	O
continuous	O
analysers	O
.	O
3	O
.	O
Correlation	O
between	O
the	O
concentration	O
of	O
various	O
kinds	O
of	O
pollutants	O
in	O
atmosphere	O
and	O
wind	O
direction	O
and	O
velocity	O
at	O
Kasumigaseki	O
,	O
central	O
district	O
of	O
Tokyo	O
]	O
[	O
Ultramicro-analysis	O
of	O
cyclohexylamine	O
and	O
low	O
fatty	O
amines	O
by	O
gas	O
chromatography	O
]	O
[	O
Some	O
knowledges	O
on	O
the	O
potency	O
of	O
heparin	O
fractions	O
obtained	O
by	O
gel	O
filtration	O
]	O
[	O
On	O
the	O
peripheral	O
effects	O
of	O
endotoxin	O
and	O
leucocyte	O
pyrogen	O
in	O
rabbit	O
]	O
[	O
A	O
tentative	O
draft	O
of	O
qualitative	O
test	O
of	O
fluoride	O
for	O
adoption	O
to	O
the	O
general	O
tests	O
of	O
eighth	O
revised	O
edition	O
of	O
the	O
Pharmacopoeia	O
of	O
Japan	O
]	O
[	O
Identification	O
of	O
tranquillizers	SYMP
by	O
thin-layer	O
chromatography	O
]	O
[	O
Analysis	O
of	O
steroids	O
.	O
II	O
.	O
A	O
note	O
on	O
the	O
assay	O
of	O
corticoid	O
preparations	O
by	O
tetrazolium	O
salt	O
]	O
[	O
Analysis	O
of	O
steroids	O
.	O
3	O
.	O
Colorimetric	O
assay	O
of	O
thiomesterone	O
]	O
[	O
Studies	O
on	O
the	O
radioimmunoassay	O
of	O
insulin	SYMP
.	O
I	O
.	O
The	O
production	O
and	O
detection	O
of	O
anti-insulin	O
serum	O
and	O
anti-guinea-pig	O
globulin	O
rabbit	O
serum	O
]	O
[	O
Synthesis	O
of	O
lysergic	O
acid	O
diethylamide	O
(	O
LSD	O
)	O
]	O
[	O
Studies	O
on	O
the	O
anti-microbial	O
activity	O
of	O
nonionic	O
and	O
anionic	O
surfactants	O
]	O
[	O
On	O
the	O
National	O
Institute	O
of	O
Hygienic	O
Sciences	O
Standard	O
``	O
lysozyme	O
standard	O
''	O
]	O
[	O
On	O
the	O
examination	O
of	O
ginseng	O
and	O
powdered	O
ginseng	O
in	O
1969	O
]	O
[	O
On	O
the	O
standardization	O
of	O
plastic	SYMP
suture	SYMP
]	O
Undergraduate	O
research	O
assistants	O
in	O
the	O
Faculty	O
of	O
Medicine	O
.	O
University	O
College	O
of	O
Rhodesia	O
.	O
[	O
Congenital	SYMP
aortic	SYMP
stenosis	SYMP
]	O
[	O
Sodium	O
in	O
heart	SYMP
failure	SYMP
]	O
[	O
Potassium	O
in	O
heart	SYMP
failure	SYMP
]	O
[	O
Hydrogen	O
ion	O
equilibrium	O
in	O
heart	SYMP
failure	SYMP
]	O
[	O
Various	O
aspects	O
of	O
water-salt	O
metabolism	O
in	O
heart	SYMP
congestive	SYMP
failure	SYMP
]	O
[	O
Clinical	O
physiopathology	O
of	O
the	O
patency	O
of	O
the	O
interatrial	O
septum	O
]	O
[	O
Various	O
aspects	O
of	O
diuresis	SYMP
in	O
heart	SYMP
congestive	SYMP
failure	SYMP
]	O
[	O
Changes	O
in	O
the	O
mechanism	O
of	O
renal	O
acidification	O
in	O
congestive	SYMP
heart	SYMP
failure	SYMP
:	O
effects	O
of	O
diuretic	SYMP
treatment	SYMP
on	O
the	O
acid-base	O
equilibrium	O
]	O
[	O
Defects	O
of	O
the	O
interventricular	O
septum	O
not	O
associated	O
with	O
other	O
malformations	O
]	O
[	O
Clinical	O
physiopathology	O
of	O
the	O
patency	O
of	O
Botallo	SYMP
's	SYMP
ductus	SYMP
arteriosus	SYMP
]	O
[	O
Clinical	O
physiopathology	O
of	O
congenital	SYMP
cyanogenic	SYMP
cardiopathies	SYMP
]	O
Electronic	O
computers	O
in	O
medical	O
education	O
of	O
the	O
future	O
.	O
Anesthesiology	O
and	O
computers	O
.	O
[	O
Immediate	O
outcome	O
and	O
long-term	O
results	O
of	O
108	O
sphincterotomies	O
of	O
Oddi	O
's	O
sphincter	O
of	O
biliary	O
indication	O
]	O
Neuraminic	O
acid-containing	O
oligosaccharides	O
of	O
human	O
urine	O
:	O
isolation	O
and	O
identification	O
of	O
di-N-acetylneuraminyl-3-galactosyl-N-acetylgalactosamine	O
,	O
6-2-Nacetylneuraminyl-lactose	O
,	O
6-2-N-acetylneuraminyl-N-acetyllactosamine	O
and	O
3-2-N-acetylneuraminyl-lactose	O
.	O
Determination	O
of	O
serum	O
oxytocinase	O
(	O
1-cystine-aminopeptidase	O
)	O
activity	O
.	O
Intolerance	O
to	O
milk	O
in	O
ulcerative	SYMP
colitis	SYMP
.	O
A	O
preliminary	O
report	O
.	O
[	O
Rhinitis	SYMP
in	O
herds	O
with	O
piglet	SYMP
influenza	SYMP
]	O
[	O
Research	O
on	O
breeding	O
hygiene	O
in	O
pigs	O
and	O
piglets	O
free	O
from	O
epidemic	SYMP
diseases	SYMP
]	O
The	O
stimulatory	O
effect	O
of	O
luteinizing	O
hormone	O
on	O
adenosine	O
3',5'-monophosphate	O
accumulation	O
in	O
corpus	O
luteum	O
slices	O
.	O
Electrolyte	O
and	O
acid-base	O
balance	O
in	O
fetal	O
and	O
maternal	O
blood	O
.	O
An	O
experimental	O
and	O
a	O
clinical	O
study	O
.	O
Q	SYMP
fever	SYMP
at	O
a	O
combined	O
meat	O
and	O
poultry	O
abattoir	O
.	O
Some	O
functional	O
and	O
morphological	O
alterations	O
occurring	O
during	O
and	O
after	O
the	O
adaptation	O
of	O
BHK	O
21	O
clone	O
13	O
cells	O
to	O
suspension	O
culture	O
.	O
Asbestos	O
as	O
an	O
urban	O
air	O
contaminant	O
.	O
Gas	O
permeability	O
of	O
plastic	O
membranes	O
for	O
artificial	SYMP
lungs	SYMP
.	O
Technoogy	O
,	O
automation	O
and	O
human	O
welfare	O
.	O
A	O
radium	O
accident	O
in	O
a	O
hospital	O
.	O
High	O
energy	O
roentgen	O
ray	O
contamination	O
of	O
the	O
electron	O
beam	O
from	O
a	O
medical	O
betatron	O
.	O
The	O
genetically	O
significant	O
dose	O
from	O
roentgen	O
examinations	O
in	O
Finland	O
in	O
1963	O
.	O
Differential	O
expression	O
of	O
fibroblast	O
growth	O
factor-2	O
and	O
receptor	O
by	O
glial	O
cells	O
in	O
experimental	O
autoimmune	SYMP
encephalomelitis	SYMP
(	SYMP
EAE	SYMP
)	SYMP
Cesarean	O
deliveries	O
at	O
a	O
university	O
hospital	O
:	O
analysis	O
of	O
rates	O
and	O
indications	O
.	O
Increase	O
in	O
ambient	O
temperature	O
may	O
explain	O
decrease	O
in	O
amniotic	O
fluid	O
index	O
.	O
Early	O
treatment	O
of	O
gestational	SYMP
diabetes	SYMP
reduces	O
the	O
rate	O
of	O
fetal	SYMP
macrosomia	SYMP
.	O
Antenatally	O
detectable	O
markers	O
for	O
the	O
diagnosis	O
of	O
autosomally	SYMP
trisomic	SYMP
fetuses	SYMP
in	O
at-risk	O
pregnancies	O
.	O
The	O
rate	O
of	O
severe	O
preeclampsia	SYMP
is	O
increased	O
in	O
triplet	O
as	O
compared	O
to	O
twin	O
gestations	O
.	O
Thermal	O
equipment	O
usage	O
patterns	O
in	O
neonatal	O
intensive	O
care	O
units	O
:	O
interunit	O
variability	O
and	O
intraunit	O
consistency	O
.	O
Massive	O
fetomaternal	SYMP
hemorrhage	SYMP
.	O
Perinatal	O
features	O
of	O
omphalocele-exstrophy-imperforate	SYMP
anus-spinal	SYMP
defects	SYMP
(	SYMP
OEIS	SYMP
complex	SYMP
)	SYMP
associated	O
with	O
large	O
meningomyeloceles	SYMP
and	O
severe	SYMP
limb	SYMP
defects	SYMP
.	O
Subchorial	SYMP
hematoma	SYMP
:	O
a	O
probable	O
cause	O
of	O
reversible	O
nonimmune	O
hydrops	O
fetalis	SYMP
.	O
Pregnancy	O
in	O
chronic	O
progressive	O
external	O
ophthalmoplegia	SYMP
:	O
a	O
case	O
report	O
.	O
Effect	O
of	O
magnesium	O
sulfate	O
on	O
the	O
development	O
of	O
cystic	O
periventricular	O
leukomalacia	SYMP
in	O
preterm	O
infants	O
.	O
TO_SEE	O
Intrapartum	O
sonography	O
of	O
the	O
lower	O
uterine	O
segment	O
in	O
patients	O
with	O
breech-presenting	O
fetuses	O
.	O
Isolated	O
persistent	O
fetal	O
bradycardia	O
in	O
complete	O
A-V	O
block	O
:	O
a	O
conservative	O
approach	O
is	O
appropriate	O
.	O
A	O
case	O
report	O
and	O
a	O
review	O
of	O
the	O
literature	O
.	O
Spontaneous	O
rectus	SYMP
sheath	SYMP
hematoma	SYMP
during	O
pregnancy	O
mimicking	O
abruptio	SYMP
placenta	SYMP
.	O
Amnioinfusion	SYMP
for	O
prevention	O
of	O
pulmonary	SYMP
hypoplasia	SYMP
in	O
second-trimester	O
rupture	O
of	O
membranes	O
.	O
Trauma	O
and	O
pregnancy	O
.	O
Fetal	O
breathing	O
movements	O
within	O
24	O
hours	O
of	O
delivery	O
in	O
prematurity	O
are	O
related	O
to	O
histologic	O
and	O
clinical	O
evidence	O
of	O
amnionitis	SYMP
.	O
Laerdal	O
infant	O
resuscitators	O
are	O
unreliable	O
as	O
free-flow	O
oxygen	O
delivery	O
devices	O
.	O
Laryngeal	SYMP
obstruction	SYMP
caused	O
by	O
lingual	SYMP
thyroglossal	SYMP
duct	SYMP
cyst	SYMP
presenting	O
at	O
birth	O
.	O
Oligohydramnios	O
and	O
the	O
appropriately	O
grown	O
fetus	O
.	O
Ultrastructure	O
of	O
human	O
colostral	O
cells	O
.	O
Dubowitz	O
assessment	O
of	O
gestational	O
age	O
and	O
agreement	O
with	O
prenatal	O
methods	O
.	O
Low	O
prenatal	O
weight	O
gain	O
among	O
low-income	O
women	O
:	O
what	O
are	O
the	O
risk	O
factors	O
?	O
Depression	SYMP
after	O
childbirth	O
:	O
the	O
views	O
of	O
medical	O
students	O
and	O
women	O
compared	O
.	O
Breastfeeding	O
and	O
the	O
use	O
of	O
pacifiers	O
.	O
Care	O
in	O
normal	O
birth	O
:	O
a	O
practical	O
guide	O
.	O
Technical	O
Working	O
Group	O
,	O
World	O
Health	O
Organization	O
.	O
Cesarean	O
sections	O
:	O
women	O
's	O
choice	O
for	O
giving	O
birth	O
?	O
Epidurals	SYMP
and	O
breastfeeding	O
.	O
Lamaze	O
and	O
Bradley	O
childbirth	O
classes	O
.	O
Concerns	O
about	O
the	O
institutionalization	O
of	O
childbirth	O
education	O
.	O
Index	O
to	O
current	O
literature	O
.	O
A	O
randomized	O
trial	O
of	O
one-to-one	O
nurse	O
support	O
of	O
women	O
in	O
labor	O
.	O
Commentary	O
:	O
are	O
nurses	O
effective	O
providers	O
of	O
labor	O
support	O
?	O
Should	O
they	O
be	O
?	O
Can	O
they	O
be	O
?	O
Women	O
's	O
views	O
of	O
different	O
models	O
of	O
antenatal	O
care	O
in	O
Victoria	O
,	O
Australia	O
.	O
The	O
effect	O
of	O
discharge	O
pack	O
formula	O
and	O
breast	O
pumps	O
on	O
breastfeeding	O
duration	O
and	O
choice	O
of	O
infant	O
feeding	O
method	O
.	O
Commentary	O
:	O
discharge	O
packs	O
:	O
how	O
much	O
do	O
they	O
matter	O
?	O
Quality	O
framework	O
for	O
force	O
plate	O
testing	O
.	O
Bone	O
registration	O
method	O
for	O
robot	SYMP
assisted	SYMP
surgery	SYMP
:	O
pedicle	O
screw	O
insertion	O
.	O
Parameter	O
sensitivity	O
of	O
a	O
mathematical	O
model	O
of	O
the	O
anterior	O
cruciate	O
ligament	O
.	O
Simultaneous	O
measurement	O
of	O
stiffness	O
and	O
energy	O
absorptive	O
properties	O
of	O
articular	O
cartilage	O
and	O
subchondral	O
trabecular	O
bone	O
.	O
Estimation	O
of	O
loads	O
and	O
stresses	O
in	O
abdominal	O
muscles	O
during	O
slow	O
lifts	O
.	O
[	O
Contralateral	O
modification	O
of	O
transitory	O
evoked	O
otoacoustic	O
emissions	O
]	O
YES	O
[	O
Mucous	SYMP
membrane	SYMP
melanomas	SYMP
of	O
the	O
upper	O
aerodigestive	O
tract	O
.	O
An	O
analysis	O
of	O
34	O
cases	O
]	O
[	O
Are	O
the	O
products	O
of	O
CD44	O
exons	O
v5	O
and	O
v6	O
markers	O
for	O
metastasis	O
of	O
laryngeal	SYMP
carcinomas	SYMP
?	O
]	O
[	O
Detection	O
of	O
differentially	O
expressed	O
genes	O
in	O
head-neck	SYMP
carcinomas	SYMP
]	O
[	O
Tuberculosis	SYMP
of	O
the	O
parotid	O
gland	O
:	O
a	O
rare	O
differential	O
diagnosis	O
of	O
parotid	SYMP
tumor	SYMP
]	O
[	O
A	O
case	O
of	O
sarcoidosis	SYMP
of	O
the	O
mastoid	O
]	O
Genomic	O
medicine	O
.	O
Internet	O
resources	O
for	O
medical	O
genetics	O
.	O
Genetics	O
.	O
A	O
piece	O
of	O
my	O
mind	O
.	O
A	O
'normal	O
'	O
practice	O
.	O
Predisposition	O
genetic	O
testing	O
for	O
late-onset	SYMP
disorders	SYMP
in	O
adults	O
.	O
A	O
position	O
paper	O
of	O
the	O
National	O
Society	O
of	O
Genetic	O
Counselors	O
.	O
Scientists	O
revel	O
in	O
new	O
research	O
tool	O
:	O
an	O
online	O
index	O
of	O
cancer	O
genes	O
.	O
Center	O
for	O
genetic	O
research	O
on	O
scleroderma	SYMP
.	O
As	O
discoveries	O
unfold	O
,	O
a	O
new	O
urgency	O
to	O
bring	O
genetic	O
literacy	O
to	O
physicians	O
.	O
>	O
From	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
.	O
Gonorrhea	SYMP
among	O
men	O
who	O
have	O
sex	O
with	O
men	O
--	O
selected	O
sexually	O
transmitted	O
diseases	O
clinics	O
,	O
1993-1996	O
.	O
>	O
From	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
.	O
Chlamydia	SYMP
screening	O
practices	O
of	O
primary-care	O
providers	O
--	O
Wake	O
County	O
,	O
North	O
Carolina	O
,	O
1996	O
.	O
Social	O
ties	O
and	O
susceptibility	O
to	O
the	O
common	SYMP
cold	SYMP
.	O
Prevention	O
of	O
bacterial	SYMP
endocarditis	SYMP
:	O
American	O
Heart	O
Association	O
recommendations	O
.	O
Prevention	O
of	O
bacterial	O
endocarditis	O
:	O
American	O
Heart	O
Association	O
recommendations	O
.	O
Prevention	O
of	O
bacterial	O
endocarditis	O
:	O
American	O
Heart	O
Association	O
recommendations	O
.	O
YES	O
Issues	O
regarding	O
antiretroviral	O
treatment	O
for	O
patients	O
with	O
HIV-1	O
infection	O
.	O
Issues	O
regarding	O
antiretroviral	O
treatment	O
for	O
patients	O
with	O
HIV-1	O
infection	O
.	O
Issues	O
regarding	O
antiretroviral	O
treatment	O
for	O
patients	O
with	O
HIV-1	O
infection	O
.	O
Prescribing	O
protease	SYMP
inhibitors	SYMP
for	O
the	O
homeless	O
.	O
YES	O
Complete	O
genomic	O
screen	O
in	O
late-onset	O
familial	O
Alzheimer	SYMP
disease	SYMP
.	O
Evidence	O
for	O
a	O
new	O
locus	O
on	O
chromosome	O
12	O
.	O
BRCA1	O
sequence	O
analysis	O
in	O
women	O
at	O
high	O
risk	O
for	O
susceptibility	O
mutations	O
.	O
Risk	O
factor	O
analysis	O
and	O
implications	O
for	O
genetic	O
testing	O
.	O
Characteristics	O
of	O
prostate	SYMP
cancer	SYMP
in	O
families	O
potentially	O
linked	O
to	O
the	O
hereditary	O
prostate	O
cancer	O
1	O
(	O
HPC1	O
)	O
locus	O
.	O
Chromosome	O
19	O
single-locus	O
and	O
multilocus	O
haplotype	O
associations	O
with	O
multiple	SYMP
sclerosis	SYMP
.	O
Evidence	O
of	O
a	O
new	O
susceptibility	O
locus	O
in	O
Caucasian	O
and	O
Chinese	O
patients	O
.	O
Cancer	SYMP
incidence	O
after	O
retinoblastoma	SYMP
.	O
Radiation	O
dose	O
and	O
sarcoma	O
risk	O
.	O
Genetic	O
testing	O
in	O
hereditary	O
colorectal	SYMP
cancer	SYMP
.	O
Molecular	O
neurogenetics	O
:	O
the	O
genome	O
is	O
settling	O
the	O
issue	O
.	O
Family	O
history	O
and	O
genetic	O
risk	O
factors	O
:	O
forward	O
to	O
the	O
future	O
.	O
Preparing	O
health	O
professionals	O
for	O
the	O
genetic	O
revolution	O
.	O
Preterm	O
premature	O
rupture	SYMP
of	SYMP
the	SYMP
membranes	SYMP
associated	O
with	O
recent	O
cocaine	O
use	O
.	O
Attitudes	O
toward	O
health-care	O
,	O
HIV	SYMP
infection	SYMP
,	O
and	O
perinatal	O
transmission	O
interventions	O
in	O
a	O
cohort	O
of	O
inner-city	O
,	O
pregnant	O
women	O
.	O
Association	O
of	O
parvovirus	SYMP
infection	SYMP
with	O
isolated	O
fetal	O
effusions	O
.	O
[	O
Early	O
and	O
long-term	O
results	O
of	O
rehabilitation	O
of	O
cochlear	SYMP
implant	SYMP
patients	O
]	O
]	O
Principles	O
of	O
signal	O
detection	O
in	O
pharmacovigilance	O
.	O
Homology	O
modeling	O
of	O
adenylosuccinate	O
synthetase	O
from	O
Saccharomyces	O
cerevisiae	O
reveals	O
a	O
possible	O
binding	O
region	O
for	O
single-stranded	O
ARS	O
sequences	O
.	O
Deletion	O
analysis	O
of	O
the	O
p16/CDKN2	O
gene	O
in	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	SYMP
using	O
quantitative	O
polymerase	O
chain	O
reaction	O
method	O
.	O
Ribosomal	O
S6	O
kinase	O
p90rsk	O
and	O
mRNA	O
cap-binding	O
protein	O
eIF4E	O
phosphorylations	O
correlate	O
with	O
MAP	O
kinase	O
activation	O
during	O
meiotic	O
reinitiation	O
of	O
mouse	O
oocytes	O
.	O
Hyaluronidase	O
activity	O
of	O
macaque	O
sperm	O
assessed	O
by	O
an	O
in	O
vitro	O
cumulus	O
penetration	O
assay	O
.	O
The	O
comparison	O
of	O
the	O
responsiveness	O
of	O
human	O
isolated	O
internal	O
mammary	O
and	O
gastroepiploic	O
arteries	O
to	O
levcromakalim	O
:	O
an	O
alternative	O
approach	O
to	O
the	O
management	O
of	O
graft	O
spasm	O
.	O
Single-dose	O
pharmacokinetics	O
of	O
felbamate	O
in	O
patients	O
with	O
renal	O
dysfunction	O
.	O
Reporting	O
of	O
adverse	O
drug	O
reactions	O
by	O
hospital	O
doctors	O
and	O
the	O
response	O
to	O
intervention	O
.	O
Glutamate	O
receptors	O
and	O
gene	O
induction	O
:	O
signalling	O
from	O
receptor	O
to	O
nucleus	O
.	O
Role	O
of	O
phosphatidylinositol	O
3-kinase	O
in	O
degranulation	O
induced	O
by	O
IgE-dependent	O
and	O
-independent	O
mechanisms	O
in	O
rat	O
basophilic	O
RBL-2H3	O
(	O
ml	O
)	O
cells	O
.	O
Platelet-derived	O
growth	O
factor	O
activates	O
a	O
mammalian	O
Ste20	O
coupled	O
mitogen-activated	O
protein	O
kinase	O
in	O
airway	O
smooth	O
muscle	O
.	O
Cyclic	O
AMP	O
inhibitors	O
inhibits	O
PDGF-stimulated	O
mitogen-activated	O
protein	O
kinase	O
activity	O
in	O
rat	O
aortic	O
smooth	O
muscle	O
cells	O
via	O
inactivation	O
of	O
c-Raf-1	O
kinase	O
and	O
induction	O
of	O
MAP	O
kinase	O
phosphatase-1	O
.	O
Mitochondrial	O
cytopathies	O
and	O
renal	SYMP
tubular	SYMP
acidosis	SYMP
.	O
YES	O
Leukaemia	SYMP
and	O
non-Hodgkin	SYMP
's	SYMP
lymphoma	SYMP
in	O
children	O
and	O
young	O
adults	O
:	O
are	O
prenatal	O
and	O
neonatal	O
factors	O
important	O
determinants	O
of	O
disease	O
?	O
Inverse	O
correlation	O
between	O
loss	O
of	O
heterozygosity	O
of	O
the	O
short	O
arm	O
of	O
chromosome	O
12	O
and	O
p15ink4B/p16ink4	O
gene	O
inactivation	O
in	O
childhood	SYMP
acute	SYMP
lymphoblastic	SYMP
leukaemia	SYMP
.	O
Drug	O
resistance	O
markers	O
:	O
are	O
they	O
bad	O
or	O
good	O
?	O
YES	O
Folate	SYMP
and	O
heart	SYMP
disease	SYMP
:	O
theoretical	O
link	O
needs	O
study	O
.	O
A	O
call	O
for	O
stepped-up	O
melanoma	SYMP
screening	O
.	O
New	O
approaches	O
to	O
stroke	SYMP
require	O
immediate	O
action	O
.	O
The	O
focus	O
is	O
now	O
on	O
standards	O
and	O
privacy	O
in	O
electronic	O
patient	O
records	O
.	O
Osteopathic	O
manifesto	O
.	O
I	O
.	O
Introduction	O
.	O
II	O
.	O
The	O
roots	O
.	O
1981	O
.	O
Treatment	O
uncertainties	O
surround	O
early	O
diagnosis	O
of	O
breast	SYMP
cancer	SYMP
.	O
Depression	SYMP
in	O
the	O
chronically	O
ill	O
needs	O
separate	O
treatment	O
.	O
Medical	O
centers	O
tackle	O
delays	O
,	O
reduce	O
wait	O
times	O
.	O
Epilepsy	O
and	O
attention	O
deficit	O
hyperactivity	O
disorder	O
:	O
is	O
methylphenidate	O
safe	O
and	O
effective	O
?	O
Applying	O
the	O
AIDS	SYMP
paradigm	O
to	O
hepatitis	SYMP
.	O
New	O
asthma	SYMP
guidelines	O
emphasize	O
better	O
diagnosis	O
,	O
stricter	O
control	O
.	O
Osteopathic	O
manifesto	O
.	O
IV	O
.	O
The	O
search	O
.	O
1981	O
.	O
Researchers	O
puzzle	O
over	O
origin	O
of	O
type	O
2	O
diabetes	SYMP
.	O
Ovarian	SYMP
cancer	SYMP
:	O
diagnostic	O
limitations	O
,	O
treatment	O
obstacles	O
.	O
Osteopathic	O
manifesto	O
.	O
V.	O
Legislative	O
and	O
legal	O
vigilance	O
.	O
1981	O
.	O
Osteopathic	O
manifesto	O
.	O
VI	O
.	O
The	O
light	O
of	O
the	O
profession	O
.	O
1981	O
.	O
Electrophysiological	O
evidence	O
on	O
the	O
time	O
course	O
of	O
semantic	O
and	O
phonological	O
processes	O
in	O
speech	O
production	O
.	O
Effects	O
of	O
alanine	O
and	O
glycine	O
substitution	O
for	O
tryptophan	O
on	O
the	O
heterogeneity	O
of	O
gramicidin	O
A	O
analogs	O
in	O
micelles	O
.	O
Torsion-angle	O
molecular	O
dynamics	O
as	O
a	O
new	O
efficient	O
tool	O
for	O
NMR	O
structure	O
calculation	O
.	O
Time-domain	O
quanification	O
of	O
amplitude	O
,	O
chemical	O
shift	O
,	O
apparent	O
relaxation	O
time	O
T2	O
,	O
and	O
phase	O
by	O
wavelet-transform	O
analysis	O
.	O
Application	O
to	O
biomedical	O
magnetic	O
resonance	O
spectroscopy	O
.	O
Investigation	O
of	O
uncertainties	O
in	O
relaxation	O
analysis	O
of	O
2D	O
NOE	O
which	O
arise	O
from	O
spectral	O
noise	O
.	O
An	O
efficient	O
HN	O
(	O
CA	O
)	O
NH	O
pluse	O
scheme	O
for	O
triple-resonance	O
4D	O
correlation	O
of	O
sequential	O
amide	O
protons	O
and	O
nitrogens-15	O
in	O
deuterated	O
proteins	O
.	O
Optimal	O
detection	O
of	O
weak	O
nJ	O
(	O
1H-	O
119Sn	O
)	O
couplings	O
by	O
gradient-enhanced	O
1D	O
and	O
2D	O
heteronuclear	O
multiple-quantum	O
correlation	O
spectroscopy	O
.	O
Application	O
to	O
a	O
novel	O
tin	O
derivative	O
of	O
erythromycin	O
A	O
.	O
Thermoelectric	O
cooling	O
for	O
NMR	O
sample	O
temperature	O
control	O
.	O
H2NCO-E.COSY	O
,	O
a	O
simple	O
method	O
for	O
the	O
sterospecific	O
assignment	O
of	O
side-chain	O
amide	O
protons	O
in	O
proteins	O
.	O
Applying	O
excitation	O
sculpting	O
to	O
construct	O
singly	O
and	O
doubly	O
selective	O
1D	O
NMR	O
experiments	O
.	O
Radiation	O
dosimetry	O
by	O
localized	O
magnetic	O
resonance	O
spectroscopy	O
.	O
The	O
2D	O
NMR	O
experiments	O
H	O
(	O
C	O
)	O
CO2	O
and	O
HCCO2	O
for	O
assignment	O
and	O
pH	O
titration	O
of	O
carboxylate	O
groups	O
in	O
uniformly	O
15N/13C-labeled	O
proteins	O
.	O
Post-acquisition	O
solvent	O
suppression	O
by	O
singular-value	O
decomposition	O
.	O
Osteopathic	O
manifesto	O
.	O
IX	O
.	O
What	O
about	O
our	O
distinctiveness	O
?	O
1981	O
.	O
Preparing	O
for	O
thalidomide	SYMP
's	SYMP
comeback	O
.	O
Heart	SYMP
disease	SYMP
:	O
women	O
's	O
unique	O
risks	O
demand	O
attention	O
.	O
Resolution	O
due	O
in	O
medical	O
software	O
regulation	O
.	O
Osteopathic	O
manifesto	O
.	O
VII	O
.	O
Shadows	O
and	O
images	O
.	O
1981	O
.	O
The	O
practical	O
use	O
of	O
PCR	O
for	O
rapid	O
detection	O
of	O
methicillin	SYMP
resistance	O
among	O
staphylococcal	O
clinical	O
isolates	O
from	O
Turkish	O
hospitals	O
.	O
YES	O
YES	O
Association	O
between	O
5-HT2A	O
gene	O
promoter	O
polymorphism	O
and	O
anorexia	SYMP
nervosa	SYMP
.	O
YES	O
State	O
regulation	O
in	O
a	O
world	O
of	O
``	O
boundary-less	O
''	O
technology	O
.	O
[	O
Screening	O
for	O
Chlamydia	SYMP
trachomatis	SYMP
?	O
]	O
Physician-assisted	O
suicide	O
in	O
Oregon	O
.	O
Common	O
nutritional	O
issues	O
in	O
pediatric	O
and	O
adult	O
critical	O
care	O
medicine	O
.	O
A	O
multifactorial	O
analysis	O
of	O
facial	O
nerve	O
results	O
in	O
surgery	O
for	O
cerebellopontine	O
angle	O
tumors	O
.	O
Osteopathic	O
manifesto	O
.	O
VIII	O
.	O
Our	O
distinct	O
image	O
.	O
1981	O
.	O
Quality	O
in	O
general	O
practice	O
.	O
Winning	O
the	O
war	O
on	O
cancer	SYMP
.	O
Winning	O
the	O
war	O
on	O
cancer	O
.	O
Clinical	O
problem-solving	O
--	O
where	O
did	O
good	O
old	O
clinical	O
diagnosis	O
go	O
?	O
The	O
named	O
nurse	O
:	O
patient	O
and	O
nurse	O
expectations	O
.	O
Genetic	O
testing	O
opens	O
brave	O
new	O
world	O
.	O
Heterologous	O
vaccines	SYMP
:	O
proponent	O
sparks	O
some	O
interest	O
.	O
Steps	O
still	O
being	O
taken	O
to	O
undo	O
damage	O
of	O
``	O
America	O
's	O
Nuremberg	O
''	O
.	O
Patient-centered	O
ethics	O
reclaiming	O
center	O
stage	O
.	O
Social	O
ties	O
and	O
susceptibility	O
to	O
the	O
common	SYMP
cold	SYMP
.	O
Connecting	O
peptide	O
,	O
correcting	O
peptide	O
?	O
Winning	O
health	O
victories	O
with	O
community	O
commitment	O
.	O
Telemedicine	O
gets	O
a	O
chance	O
to	O
prove	O
itself	O
.	O
Additional	O
opinions	O
on	O
the	O
mortality	O
of	O
animal	O
research	O
.	O
Recurrent	SYMP
strokes	SYMP
in	O
a	O
34-year-old	O
man	O
.	O
A	O
plan	O
for	O
improving	O
outcomes	O
for	O
patients	O
with	O
chronic	SYMP
renal	SYMP
failure	SYMP
.	O
[	O
Scientific	O
evidence	O
in	O
family	O
and	O
community	O
medicine	O
]	O
Evidence	O
that	O
the	O
expression	O
of	O
progesterone-induced	O
blocking	O
factor	O
by	O
maternal	O
T-lymphocytes	O
is	O
positively	O
correlated	O
with	O
conception	O
.	O
YES	O
Isotopic	O
evidence	O
for	O
extraterrestrial	O
non-racemic	O
amino	O
acids	O
in	O
the	O
Murchison	O
meteorite	O
.	O
The	O
American	O
Medical	O
Association	O
Guidelines	O
for	O
Adolescent	O
Preventive	O
Services	O
.	O
Classification	O
of	O
malignant	SYMP
lymphomas	SYMP
:	O
the	O
updated	O
Kiel	O
classification	O
.	O
Rethink	O
on	O
screening	O
for	O
breast	SYMP
cancer	SYMP
.	O
Sports-related	O
ocular	SYMP
injuries	SYMP
.	O
Fruit	O
juice	O
consumption	O
.	O
The	O
case	O
of	O
the	O
missing	O
methylphenidate	SYMP
.	O
TO_SEE	O
GPs	O
'	O
perceptions	O
of	O
tolerability	O
of	O
selective	O
serotonin	O
reuptake	O
inhibitors	O
and	O
tricyclic	O
antidepressants	SYMP
.	O
Research	O
into	O
long	O
term	O
use	O
is	O
needed	O
.	O
Diagnosing	O
and	O
managing	O
polymyalgia	SYMP
rheumatica	SYMP
and	O
temporal	SYMP
arteritis	SYMP
.	O
Sensitivity	O
of	O
temporal	O
artery	O
biopsy	O
varies	O
with	O
biopsy	O
length	O
and	O
sectioning	O
strategy	O
.	O
Obstructive	O
sleep	SYMP
apnoea	SYMP
.	O
Authors	O
'	O
reply	O
.	O
Impact	O
of	O
postmenopausal	O
hormone	SYMP
therapy	SYMP
on	O
cardiovascular	O
events	O
and	O
cancer	SYMP
.	O
Search	O
for	O
studies	O
was	O
limited	O
.	O
Treating	O
shoulder	O
complaints	O
in	O
general	O
practice	O
.	O
Diagnostic	O
criteria	O
must	O
be	O
used	O
and	O
therapeutic	O
regimens	O
standardised	O
.	O
Authorship	O
.	O
System	O
acknowledging	O
roles	O
of	O
contributors	O
is	O
best	O
.	O
Authorship	O
.	O
New	O
authorship	O
practices	O
are	O
needed	O
in	O
developing	O
countries	O
.	O
Authorship	O
.	O
Researchers	O
'	O
objective	O
is	O
to	O
get	O
the	O
job	O
done	O
.	O
Quality	O
and	O
clinical	O
audit	O
.	O
Transurethral	SYMP
microwave	SYMP
thermotherapy	SYMP
.	O
Management	O
of	O
ileosigmoid	SYMP
knotting	SYMP
.	O
Epitome	O
of	O
myocarditis	SYMP
.	O
Producing	O
consistent	O
estimates	O
of	O
the	O
power	O
spectral	O
density	O
of	O
NN	O
sequences	O
.	O
Environmental	O
tobacco	O
smoke	O
and	O
coronary	SYMP
heart	SYMP
disease	SYMP
.	O
Long-term	O
benefit	O
of	O
one	O
thrombolytic	SYMP
over	O
another	O
.	O
Coupling	O
of	O
hemodynamic	O
measurements	O
with	O
oxygen	O
during	O
exercise	O
does	O
not	O
improve	O
risk	O
stratification	O
in	O
patients	O
with	O
heart	SYMP
failure	SYMP
.	O
Smoking	O
--	O
good	O
or	O
bad	O
for	O
semen	O
?	O
The	O
pruning	O
of	O
Doctor	O
McDonough	O
and	O
the	O
``	O
humanizing	O
''	O
of	O
statistics	O
.	O
Violence	O
.	O
Prevention	O
in	O
the	O
home	O
health	O
setting	O
.	O
Contempo	O
1997	O
:	O
obstetrics	O
and	O
gynecology	O
.	O
Mortality	O
and	O
refusal	O
of	O
ICU	O
admission	O
.	O
Extracorporeal	O
photopheresis	O
in	O
SÃ	O
(	O
c	O
)	O
zary	O
syndrome	O
.	O
Attacks	O
on	O
tobacco	O
industry	O
.	O
Does	O
blinding	O
of	O
readers	O
affect	O
results	O
of	O
meta-analyses	O
?	O
Consumption	O
of	O
alcohol	O
and	O
mortality	O
in	O
Russia	O
.	O
Presenilin	O
polymorphisms	O
in	O
Alzheimer	SYMP
's	SYMP
disease	SYMP
.	O
Autoimmune	SYMP
enteropathy	SYMP
in	O
adults	O
.	O
Cyclosporiasis	SYMP
and	O
raspberries	O
.	O
Protean	O
agonists	O
.	O
Keys	O
to	O
receptor	O
active	O
states	O
?	O
Kinetic	O
models	O
of	O
ion	O
channels	O
.	O
Agonist	O
efficacy	O
and	O
allosteric	O
models	O
of	O
receptor	O
action	O
.	O
Receptor	O
Classification	O
:	O
The	O
Integration	O
of	O
Operational	O
,	O
Structural	O
,	O
and	O
Transductional	O
Information	O
.	O
Conference	O
proceedings	O
.	O
Verona	O
,	O
Italy	O
,	O
September	O
21-22	O
,	O
1995	O
.	O
Policies	O
for	O
posting	O
biomedical	O
journal	O
information	O
on	O
the	O
Internet	O
.	O
International	O
Committee	O
of	O
Medical	O
Journal	O
Editors	O
.	O
Who	O
understands	O
the	O
menopause	O
?	O
Comparison	O
of	O
two	O
methods	O
of	O
screening	O
for	O
genital	O
chlamydial	SYMP
infection	SYMP
in	O
women	O
attending	O
in	O
general	O
practice	O
:	O
cross	O
sectional	O
survey	O
.	O
YES	O
MÃ1/4llerian	O
agenesis	O
:	O
an	O
update	O
.	O
The	O
US	O
attack	O
on	O
Cuba	O
's	O
health	O
.	O
Patient	O
consent	O
for	O
publication	O
and	O
the	O
health	O
of	O
the	O
public	O
.	O
Brain	SYMP
serotonin	SYMP
neurotoxicity	SYMP
and	O
primary	SYMP
pulmonary	SYMP
hypertension	SYMP
from	O
fenfluramine	SYMP
and	O
dexfenfluramine	SYMP
.	O
Battling	O
HI	SYMP
on	O
many	O
fronts	O
.	O
Medical	O
Injury	O
Compensation	O
Reform	O
Act	O
:	O
good	O
or	O
bad	O
?	O
Fever	O
of	O
unknown	O
origin	O
.	O
YES	O
Researchers	O
make	O
slow	O
headway	O
in	O
managing	O
dry	SYMP
mouth	SYMP
.	O
A	O
kinder	O
,	O
gentler	O
approach	O
.	O
Putting	O
patients	O
first	O
?	O
Managing	O
the	O
anxious	O
and	O
phobic	O
dental	O
patient	O
.	O
Do	O
it	O
or	O
lose	O
it	O
.	O
Assessment	O
of	O
fetal	O
nuchal	O
translucency	O
test	O
for	O
Down	SYMP
's	SYMP
syndrome	SYMP
.	O
Amiodarone	SYMP
and	O
thyroid	O
function	O
.	O
YES	O
Death	O
rates	O
from	O
childhood	SYMP
leukaemia	SYMP
near	O
nuclear	O
sites	O
.	O
Other	O
studies	O
showed	O
that	O
radiation	O
levels	O
in	O
Newbury	O
area	O
were	O
low	O
.	O
Haemoptysis	SYMP
:	O
a	O
rare	O
cause	O
.	O
Human	SYMP
papillomavirus	SYMP
types	O
52	O
and	O
58	O
are	O
prevalent	O
in	O
cervical	SYMP
cancer	SYMP
from	O
Chinese	O
women	O
.	O
Breastfeeding	O
after	O
early	O
discharge	O
.	O
Malnutrition	SYMP
and	O
microcephaly	SYMP
in	O
Australian	O
aboriginal	O
children	O
.	O
TO_SEE	O
Generalised	O
caseous	SYMP
lymphadenitis	SYMP
.	O
Public	O
health	O
approach	O
to	O
activated	O
protein	O
C	O
resistance	O
assay	O
.	O
Hormone	SYMP
replacement	SYMP
therapy	SYMP
.	O
Dose-volume	O
histograms	O
can	O
be	O
interpreted	O
in	O
different	O
ways	O
.	O
Addressing	O
needle-stick	O
concerns	O
.	O
Cervical	SYMP
cancer	SYMP
screening	O
.	O
CyberCHEST	O
.	O
An	O
open	O
future	O
.	O
Keeping	O
us	O
on	O
our	O
toes	O
!	O
Thalidomide	O
in	O
oral	O
Crohn	O
's	O
disease	O
refractory	O
to	O
conventional	O
medical	O
treatment	O
.	O
Mortality	O
and	O
length	O
of	O
stay	O
in	O
teaching	O
vs	O
nonteaching	O
hospitals	O
.	O
Early	O
discharge	O
of	O
newborns	O
.	O
Patient	O
consent	O
for	O
publication	O
.	O
[	O
Flucticasone	SYMP
propionate	SYMP
is	O
safe	O
in	O
recommended	O
doses	O
]	O
Fetal	O
nuchal	O
translucency	O
test	O
for	O
Down	SYMP
's	SYMP
syndrome	SYMP
.	O
Treatment	O
of	O
hypertension	SYMP
in	O
elderly	O
patients	O
.	O
Meta-analyses	O
and	O
large	O
randomized	O
,	O
controlled	O
trials	O
.	O
Low-fat	O
diets	O
.	O
Ultrasonographic	O
evaluation	O
of	O
parathyroid	SYMP
hyperplasia	SYMP
.	O
Misconceptions	O
about	O
mosaicism	SYMP
.	O
Are	O
normal	O
hearing	O
thresholds	O
a	O
sufficient	O
condition	O
for	O
click-evoked	O
otoacoustic	O
emissions	O
?	O
Structure	O
and	O
in	O
vitro	O
substrate	O
specificity	O
of	O
the	O
murine	O
multidrug	O
resistance-associated	O
protein	O
.	O
ATP-dependent	O
transport	O
of	O
lipophilic	O
cytotoxic	O
drugs	O
by	O
membrane	O
vesicles	O
prepared	O
from	O
MRP-overexpressing	O
HL60/ADR	O
cells	O
.	O
Cellular	O
and	O
in	O
vitro	O
transport	O
of	O
glutathione	O
conjugates	O
by	O
MRP	O
.	O
Dominant	O
negative	O
and	O
cooperative	O
effects	O
of	O
mutant	O
forms	O
of	O
prolactin	O
receptor	O
.	O
Effect	O
of	O
calcium	O
and	O
vitamin	O
D	O
supplementation	O
on	O
bone	O
density	O
in	O
men	O
and	O
women	O
65	O
years	O
of	O
age	O
or	O
older	O
.	O
Infection	O
control	O
and	O
contaminated	O
waste	O
disposal	O
practices	O
in	O
Southern	O
Sydney	O
Area	O
Health	O
Service	O
Dental	O
Clinics	O
.	O
Vitamins	O
and	O
minerals	O
:	O
efficacy	O
and	O
safety	O
.	O
Joint	O
Commission	O
on	O
Accreditation	O
of	O
Healthcare	O
Organizations	O
'	O
infection	O
control	O
requirements	O
:	O
fact	O
or	O
fiction	O
?	O
Poppy	O
tea	O
and	O
the	O
baker	O
's	O
first	O
seizure	SYMP
.	O
ABC	O
of	O
mental	O
health	O
.	O
Mental	O
health	O
and	O
the	O
law	O
.	O
Female	O
embryonic	O
lethality	O
in	O
mice	O
nullizygous	O
for	O
both	O
Msh2	O
and	O
p53	O
.	O
Tests	O
of	O
the	O
double-strand	O
break	O
,	O
lethal-potentially	O
lethal	O
and	O
repair-misrepair	O
models	O
for	O
mammalian	O
cell	O
survival	O
using	O
data	O
for	O
survival	O
as	O
a	O
function	O
of	O
delayed-plating	O
interval	O
for	O
log-phase	O
Chinese	O
hamster	O
V79	O
cells	O
.	O
Influence	O
of	O
physician	O
confidentiality	O
assurances	O
on	O
adolescents	O
'	O
willingness	O
to	O
disclose	O
information	O
and	O
seek	O
future	O
health	O
care	O
.	O
A	O
randomized	O
controlled	O
trial	O
.	O
Fever	SYMP
in	O
Africa	O
:	O
do	O
patients	O
know	O
when	O
they	O
are	O
hot	O
?	O
YES	O
Systemic	O
absorption	O
of	O
sunscreen	O
after	O
topical	O
application	O
.	O
YES	O
Evaluation	O
and	O
management	O
of	O
traumatic	SYMP
lacerations	SYMP
.	O
Atrial	SYMP
fibrillation	SYMP
begets	O
trouble	O
.	O
Ethics	O
of	O
HIV	O
trials	O
.	O
The	O
ethics	O
industry	O
.	O
Fever	SYMP
in	O
Africa	O
and	O
WHO	O
recommendation	O
.	O
[	O
''	SYMP
Whiplash	SYMP
''	SYMP
injury	SYMP
of	O
the	O
cervical	O
spine	O
:	O
value	O
of	O
modern	O
diagnostic	O
imaging	O
]	O
Guidelines	O
and	O
cardiac	O
anaesthetists	O
.	O
YES	O
Lansoprazole	SYMP
,	O
H.	O
pylori	O
,	O
and	O
atrophic	SYMP
gastritis	SYMP
.	O
Help	O
wanted	O
:	O
ultrasonographers	O
.	O
``	O
Children	O
are	O
not	O
supposed	O
to	O
die	O
.	O
''	O
Combined	O
pediatric	O
and	O
radiation	O
oncology	O
grand	O
rounds	O
addresses	O
severe	O
illness	O
and	O
death	O
.	O
Structure-activity	O
and	O
mechanism	O
studies	O
on	O
silicon	O
phthalocyanines	O
with	O
Plasmodium	O
falciparum	O
in	O
the	O
dark	O
and	O
under	O
red	O
light	O
.	O
The	O
importance	O
of	O
being	O
where	O
?	O
Balancing	O
the	O
perspective	O
on	O
practice	O
coverage	O
.	O
Effects	O
of	O
dobutamine	SYMP
at	O
maximally	O
tolerated	O
dose	O
on	O
myocardial	O
blood	O
flow	O
in	O
humans	O
with	O
ischemic	SYMP
heart	SYMP
disease	SYMP
.	O
Cholesterol-lowering	SYMP
therapy	SYMP
.	O
Ion	O
composition	O
of	O
airway	O
surface	O
liquid	O
of	O
patients	O
with	O
cystic	SYMP
fibrosis	SYMP
as	O
compared	O
with	O
normal	O
and	O
disease-control	O
subjects	O
.	O
[	O
Research	O
in	O
Copenhagen	O
hospitals	O
--	O
a	O
bibliometric	O
evaluation	O
]	O
More	O
on	O
infertility	SYMP
.	O
Dermatobia	O
--	O
tropical	SYMP
myiasis	SYMP
.	O
Progressive	O
sensorineural	O
hearing	SYMP
loss	SYMP
,	O
subjective	O
tinnitus	SYMP
and	O
vertigo	SYMP
caused	O
by	O
elevated	O
blood	O
lipids	O
.	O
Chronic	O
telogen	SYMP
effluvium	SYMP
:	O
potential	O
complication	O
for	O
clinical	O
trials	O
in	O
female	O
androgenetic	SYMP
alopecia	SYMP
?	O
TO_SEE	O
Treatment	O
of	O
suicidal	O
patients	O
.	O
The	O
systemic	O
amyloidoses	SYMP
.	O
YES	O
[	O
Mutual	O
relationships	O
based	O
on	O
equality	O
.	O
Specialists	O
and	O
nurses	O
:	O
the	O
pillars	O
of	O
hospital	O
care	O
]	O
Disability	O
models	O
in	O
geriatrics	O
:	O
comprehensive	O
rather	O
than	O
competing	O
models	O
should	O
be	O
promoted	O
.	O
Ethical	O
issues	O
in	O
interventional	SYMP
radiology	SYMP
.	O
Taking	O
issue	O
with	O
UK	O
funding	O
priorities	O
.	O
YES	O
Wegener	SYMP
's	SYMP
granulomatosis	SYMP
from	O
infancy	O
to	O
adolescence	O
.	O
Hormonal	O
responses	O
to	O
restraint	O
in	O
rhesus	O
monkeys	O
.	O
Planned	O
parenthood	O
and	O
artifical	O
selection	O
.	O
Valvular	SYMP
heart	SYMP
disease	SYMP
associated	O
with	O
fenfluramine-phentermine	SYMP
.	O
The	O
role	O
of	O
procedures	O
in	O
family	O
practice	O
:	O
is	O
there	O
a	O
right	O
answer	O
?	O
YES	O
Methadone	SYMP
maintenance	SYMP
treatment	SYMP
:	O
a	O
Canadian	O
perspective	O
.	O
Survey	O
on	O
rotavirus	SYMP
infections	SYMP
in	O
a	O
German	O
pediatric	O
hospital	O
.	O
Stroke	SYMP
incidence	O
rates	O
among	O
black	O
residents	O
of	O
Harare	O
--	O
a	O
prospective	O
community-based	O
study	O
.	O
Long-term	O
effect	O
of	O
calcium	O
supplementation	O
during	O
pregnancy	O
on	O
the	O
blood	O
pressure	O
of	O
offspring	O
:	O
follow	O
up	O
of	O
a	O
randomised	O
controlled	O
trial	O
.	O
The	O
catalytic	O
role	O
of	O
carbon	O
dioxide	O
in	O
the	O
decomposition	O
of	O
peroxynitrite	O
.	O
Unethical	O
trials	O
of	O
interventions	O
to	O
reduce	O
perinatal	O
transmission	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
in	O
developing	O
countries	O
.	O
YES	O
DOTS	O
--	O
are	O
we	O
over-optimistic	O
?	O
Activation	O
at	O
the	O
germinal	O
vesicle	O
stage	O
of	O
starfish	O
oocytes	O
produces	O
parthenogenetic	O
development	O
through	O
the	O
failure	O
of	O
polar	O
body	O
extrusion	O
.	O
Female	O
genital	O
mutilation	O
:	O
a	O
contemporary	O
issue	O
,	O
and	O
a	O
Victorian	O
obsession	O
.	O
Early	O
death	O
amongst	O
anaesthetists	O
.	O
Fluoride	SYMP
treatment	SYMP
increased	O
serum	O
IGF-1	O
,	O
bone	O
turnover	O
,	O
and	O
bone	O
mass	O
,	O
but	O
not	O
bone	O
strength	O
,	O
in	O
rabbits	O
.	O
Retrospective	O
comparison	O
of	O
techniques	O
to	O
prevent	O
secondary	SYMP
cataract	SYMP
formation	SYMP
after	O
posterior	O
chamber	O
intraocular	O
lens	SYMP
implantation	SYMP
in	O
infants	O
and	O
children	O
.	O
Serotonin	O
as	O
a	O
regulator	O
of	O
hypothalamic-pituitary-interrenal	O
activity	O
in	O
teleost	O
fish	O
.	O
Predicting	O
functional	O
appliance	O
treatment	O
outcome	O
in	O
Class	O
II	O
malocclusions	SYMP
--	O
a	O
review	O
.	O
Effect	O
of	O
cereal	O
fibre	O
source	O
and	O
processing	O
on	O
rectal	O
epithelial	O
cell	O
proliferation	O
.	O
Update	O
:	O
influenza	SYMP
activity	O
--	O
worldwide	O
,	O
March-August	O
1997	O
.	O
A	O
drop	O
in	O
pediatric	O
subject	O
examination	O
scores	O
after	O
curriculum	O
changes	O
that	O
emphasize	O
general	O
pediatric	O
topics	O
.	O
Paradigms	O
and	O
the	O
rise	O
(	O
or	O
fall	O
?	O
)	O
of	O
molecular	O
biology	O
.	O
Water	O
fluoridation	O
,	O
tooth	SYMP
decay	SYMP
in	O
5	O
year	O
olds	O
,	O
and	O
social	O
deprivation	O
measured	O
by	O
the	O
Jarman	O
score	O
:	O
analysis	O
of	O
data	O
from	O
British	O
dental	O
surveys	O
.	O
The	O
diabetes	SYMP
audit	O
and	O
research	O
in	O
Tayside	O
Scotland	O
(	O
DARTS	O
)	O
study	O
:	O
electronic	O
record	O
linkage	O
to	O
create	O
a	O
diabetes	O
register	O
.	O
DARTS/MEMO	O
Collaboration	O
.	O
Pharmaceutical	O
industry	O
is	O
invited	O
to	O
respond	O
to	O
amnesty	O
for	O
unreported	O
trials	O
.	O
Should	O
we	O
screen	O
for	O
gestational	SYMP
diabetes	SYMP
?	O
Vesico-uterine	SYMP
fistula	SYMP
--	O
a	O
rare	O
complication	O
of	O
vacuum	SYMP
extraction	SYMP
in	O
a	O
patient	O
with	O
previous	O
caesarean	SYMP
section	SYMP
.	O
Managing	O
endophthalmitis	SYMP
.	O
[	O
The	O
plug	O
and	O
patch	O
repair	O
for	O
managing	O
the	O
inguinal	O
hernia	O
of	O
the	O
adult	O
]	O
Human	O
herpesvirus	O
8	O
variants	O
in	O
sarcoid	O
tissues	O
.	O
Practice	O
parameters	O
for	O
the	O
assessment	O
and	O
treatment	O
of	O
children	O
and	O
adolescents	O
with	O
schizophrenia	SYMP
.	O
American	O
Academy	O
of	O
Child	O
and	O
Adolescent	O
Psychiatry	O
.	O
Practice	O
parameters	O
for	O
the	O
psychiatric	O
assessment	O
of	O
infants	O
and	O
toddlers	O
(	O
0-36	O
months	O
)	O
.	O
American	O
Academy	O
of	O
Child	O
and	O
Adolescent	O
Psychiatry	O
.	O
Practice	O
parameters	O
for	O
the	O
forensic	O
evaluation	O
of	O
children	O
and	O
adolescents	O
who	O
may	O
have	O
been	O
physically	O
or	O
sexually	O
abused	O
.	O
American	O
Academy	O
of	O
Child	O
and	O
Adolescent	O
Psychiatry	O
.	O
Practice	O
parameters	O
for	O
the	O
psychiatric	O
assessment	O
of	O
children	O
and	O
adolescents	O
.	O
American	O
Academy	O
of	O
Child	O
and	O
Adolescent	O
Psychiatry	O
.	O
Alternative	O
medicine	O
.	O
Leprosy	SYMP
beyond	O
the	O
year	O
2000	O
.	O
Effect	O
of	O
danaparoid	SYMP
sodium	SYMP
on	O
hard	O
exudates	O
in	O
diabetic	SYMP
retinopathy	SYMP
.	O
Lead	O
based	O
paint	O
hazards	O
in	O
early	O
childhood	O
centres	O
in	O
the	O
Wellington	O
region	O
.	O
Gene	O
technology	O
and	O
democracy	O
.	O
Use	O
of	O
statins	SYMP
.	O
Adequacy	O
of	O
SMAC	O
's	O
statement	O
should	O
be	O
judged	O
by	O
clinicians	O
,	O
not	O
health	O
economists	O
.	O
Use	O
of	O
statins	O
.	O
Glasgow	O
has	O
already	O
produced	O
strategy	O
for	O
treatment	O
.	O
Use	O
of	O
statins	O
.	O
Evidence	O
on	O
effectiveness	O
is	O
stronger	O
for	O
statins	SYMP
than	O
for	O
other	O
treatments	O
.	O
Evidence	O
based	O
advertising	O
?	O
Half	O
of	O
drug	O
advertisements	O
in	O
BMJ	O
over	O
six	O
months	O
cited	O
no	O
supporting	O
evidence	O
.	O
YES	O
Drugs	O
for	O
the	O
Third	O
World	O
.	O
Getting	O
a	O
handle	O
on	O
the	O
molecules	O
that	O
guide	O
axons	O
.	O
The	O
functional	O
neuroanatomy	O
of	O
episodic	O
memory	O
retrieval	O
.	O
Re	O
:	O
``	O
Biologic	O
synergism	O
and	O
parallelism	O
''	O
.	O
Shifting	O
medical	O
education	O
from	O
the	O
icebox	O
to	O
the	O
refrigerator	O
.	O
Reattendance	O
and	O
complications	O
in	O
a	O
randomised	O
trial	O
of	O
prescribing	O
strategies	O
for	O
sore	O
throat	O
:	O
the	O
medicalising	O
effect	O
of	O
prescribing	O
antibiotics	O
.	O
Pure	SYMP
alexia	SYMP
could	O
not	O
be	O
a	O
disconnection	O
syndrome	O
.	O
A	O
randomized	O
,	O
double-blind	O
,	O
dose-response	O
comparison	O
of	O
epidural	SYMP
fentanyl	SYMP
versus	O
sufentanil	SYMP
analgesia	SYMP
after	O
cesarean	SYMP
section	SYMP
.	O
TO_SEE	O
Spontaneous	O
splenic	SYMP
rupture	SYMP
following	O
administration	O
of	O
granulocyte	SYMP
colony-stimulating	SYMP
factor	SYMP
(	SYMP
G-CSF	SYMP
)	SYMP
:	O
occurrence	O
in	O
an	O
allogeneic	O
donor	O
of	O
peripheral	O
blood	O
stem	O
cells	O
.	O
Evidence-based	O
medicine	O
and	O
general	O
practice	O
.	O
Koch	O
's	O
or	O
Crohn	O
's	O
?	O
YES	O
Haemodynamic	O
performance	O
of	O
a	O
16-mm	O
Carbomedics	O
aortic	O
prosthesis	O
.	O
Case	O
records	O
of	O
the	O
Massachusetts	O
General	O
Hospital	O
.	O
Weekly	O
clinicopathological	O
exercises	O
.	O
Case	O
30-1997	O
.	O
A	O
preterm	O
newborn	O
female	O
triplet	O
with	O
diffuse	O
cystic	O
changes	O
in	O
the	O
left	O
lung	O
.	O
Cure	O
of	O
Helicobacter	SYMP
pylori	SYMP
infection	SYMP
improves	O
gastric	O
acid	O
secretion	O
in	O
patients	O
with	O
corpus	SYMP
gastritis	SYMP
.	O
TO_SEE	O
Pediatric	SYMP
cervical	SYMP
spine	SYMP
injury	SYMP
sustained	O
in	O
falls	O
from	O
low	O
heights	O
.	O
Prophylaxis	O
after	O
occupational	O
exposure	O
to	O
HIV	O
.	O
How	O
critical	O
are	O
critical	O
values	O
?	O
YES	O
A	O
classification	O
of	O
nucleotide-diphospho-sugar	O
glycosyltransferases	O
based	O
on	O
amino	O
acid	O
sequence	O
similarities	O
.	O
EU	O
directive	O
on	O
bovine	SYMP
spongiform	SYMP
encephalopathy	SYMP
will	O
not	O
affect	O
drugs	O
.	O
Management	O
of	O
patients	O
with	O
HIV/AIDS	SYMP
.	O
Who	O
should	O
care	O
?	O
Anesthesiology	O
.	O
Second	O
of	O
two	O
parts	O
.	O
Overdrugging	O
and	O
undertreatment	O
in	O
primary	O
health	O
care	O
.	O
Transesophageal	O
echocardiography	O
probe	O
holder	O
.	O
Pregnancy	O
outcomes	O
in	O
women	O
with	O
gestational	SYMP
diabetes	SYMP
compared	O
with	O
the	O
general	O
obstetric	O
population	O
.	O
Confidentiality	O
as	O
a	O
barrier	O
to	O
treatment	O
.	O
Recombinant	O
human	O
DNase	O
(	O
rhDNase	O
)	O
influences	O
phospholipid	O
composition	O
,	O
surface	O
activity	O
,	O
rheology	O
and	O
consecutively	O
clearance	O
indices	O
of	O
cystic	SYMP
fibrosis	SYMP
sputum	O
.	O
Palliative	O
options	O
of	O
last	O
resort	O
:	O
a	O
comparison	O
of	O
voluntarily	O
stopping	O
eating	O
and	O
drinking	O
,	O
terminal	O
sedation	O
,	O
physician-assisted	O
suicide	O
,	O
and	O
voluntary	O
active	O
euthanasia	O
.	O
Automation	O
in	O
cervical	O
cytology	O
:	O
whose	O
cost	O
and	O
whose	O
benefit	O
?	O
Losing	O
weight	O
--	O
an	O
ill-fated	O
New	O
Year	O
's	O
resolution	O
.	O
Lumbar	SYMP
puncture	SYMP
need	O
n't	O
be	O
a	O
headache	O
.	O
Profiting	O
from	O
closure	O
:	O
the	O
private	O
finance	O
initiative	O
and	O
the	O
NHS	O
.	O
Incidence	O
of	O
dog	SYMP
bite	SYMP
injuries	SYMP
treated	O
in	O
emergency	O
departments	O
.	O
Use	O
of	O
rotational	O
movements	O
to	O
remove	O
mandibular	O
molars	O
.	O
Comparison	O
of	O
three	O
methods	O
used	O
for	O
assessment	O
of	O
pain	SYMP
in	O
dogs	O
.	O
YES	O
Single-breath	O
diffusing	O
capacities	O
for	O
NO	O
,	O
CO	O
and	O
C18O2	O
in	O
rabbits	O
.	O
[	O
Improved	O
control	O
will	O
provide	O
better	O
quality	O
.	O
Interview	O
by	O
Tom	O
Heinemann	O
.	O
]	O
Case	O
of	O
the	O
month	O
.	O
Autopsy	O
Committee	O
of	O
the	O
College	O
of	O
American	O
Pathologists	O
.	O
Cor	O
pulmonale	O
.	O
Human	O
papillomavirus	O
in	O
the	O
woman	O
with	O
HIV	O
.	O
Reducing	O
risk	O
is	O
best	O
strategy	O
.	O
The	O
realpolitik	O
of	O
a	O
new	O
National	O
Health	O
Service	O
for	O
the	O
UK	O
.	O
What	O
is	O
your	O
diagnosis	O
?	O
Foreign	O
body	O
in	O
the	O
abdomen	O
.	O
Septic	SYMP
arthritis	SYMP
.	O
Brain	SYMP
tumours	SYMP
and	O
mobile	O
phones	O
?	O
[	O
Lung	SYMP
cancer	SYMP
,	O
tobacco	O
smoking	O
and	O
environmental	O
factors	O
in	O
Denmark	O
]	O
Emergency	O
department	O
use	O
as	O
a	O
component	O
of	O
total	O
ambulatory	O
care	O
:	O
a	O
population	O
perspective	O
.	O
Occupational	SYMP
therapy	SYMP
and	O
outcomes	O
for	O
older	O
adults	O
.	O
Anesthesiology	O
.	O
Low-molecular-weight	O
heparins	O
.	O
Case	O
30-1997	O
:	O
pulmonary	SYMP
interstitial	SYMP
emphysema	SYMP
in	O
infancy	O
.	O
The	O
tobacco	O
settlement	O
.	O
Two	O
actions	O
are	O
possible	O
for	O
doctors	O
wanting	O
to	O
promote	O
human	O
welfare	O
in	O
Africa	O
.	O
Carcinogenesis	O
in	O
transgenic	O
mouse	O
models	O
.	O
Trouble	O
in	O
paradise	O
.	O
Atomic	O
legacy	O
in	O
the	O
Marshall	O
Islands	O
.	O
The	O
road	O
to	O
justice	O
.	O
Solvent	O
solution	O
.	O
[	O
Role	O
of	O
free	O
radicals	O
,	O
telomeres	O
,	O
and	O
telomerases	O
in	O
aging	O
and	O
cancerogenesis	O
]	O
The	O
effect	O
of	O
ephedrine	O
on	O
the	O
onset	O
time	O
of	O
rocuronium	O
.	O
Antibody	O
class	O
switch	O
recombinase	O
activity	O
is	O
B	O
cell	O
stage	O
specific	O
and	O
functions	O
stochastically	O
in	O
the	O
absence	O
of	O
'targeted	O
accessibility	O
'	O
control	O
.	O
Systematic	O
review	O
of	O
prophylactic	O
vs	O
rescue	O
surfactant	O
.	O
The	O
safety-net	O
role	O
of	O
international	O
medical	O
graduates	O
.	O
The	O
prevalence	O
of	O
chemical	O
substance	O
and	O
alcohol	O
abuse	O
in	O
an	O
obstetric	O
population	O
in	O
Dublin	O
.	O
schizophrenia	SYMP
as	O
failure	O
of	O
hemispheric	O
dominance	O
for	O
language	O
.	O
Late	O
prenatal	O
ultrasound	O
features	O
of	O
hydrometrocolpos	O
secondary	O
to	O
cloacal	SYMP
anomaly	SYMP
:	O
case	O
reports	O
and	O
review	O
of	O
the	O
literature	O
.	O
Familial	O
and	O
primary	O
(	O
AL	O
)	O
cardiac	SYMP
amyloidosis	SYMP
:	O
echocardiographically	O
similar	O
diseases	O
with	O
distinctly	O
different	O
clinical	O
outcomes	O
.	O
Diabetic	O
retinopathy	O
,	O
promoter	O
(	O
4G/5G	O
)	O
polymorphism	O
of	O
PAI-1	O
gene	O
,	O
and	O
PAI-1	O
activity	O
in	O
Pima	O
Indians	O
with	O
type	O
2	O
diabetes	SYMP
.	O
Evaluation	O
of	O
diagnostic	O
peritoneal	O
lavage	O
in	O
stable	O
patients	O
with	O
gunshot	SYMP
wounds	SYMP
to	O
the	O
abdomen	O
.	O
Cerebral	SYMP
abscesses	SYMP
in	O
a	O
patient	O
with	O
AIDS	SYMP
caused	O
by	O
methicillin-resistant	O
Staphylococcus	O
aureus	O
(	O
MRSA	O
)	O
A	O
randomised	O
comparison	O
of	O
the	O
EuroQol	O
and	O
Short	O
Form-36	O
after	O
stroke	SYMP
.	O
United	O
Kingdom	O
collaborators	O
in	O
the	O
International	O
Stroke	O
Trial	O
.	O
[	O
Clinical	O
significance	O
of	O
Blastocystis	SYMP
hominis	SYMP
infection	SYMP
:	O
epidemiologic	O
study	O
]	O
Karolinska	O
Institute	O
rocked	O
by	O
research	O
misconduct	O
.	O
TO_SEE	O
Where	O
next	O
in	O
the	O
treatment	O
of	O
rectal	SYMP
cancer	SYMP
?	O
GAPS	O
(	O
AMA	O
Guidelines	O
for	O
Adolescent	O
Preventive	O
Services	O
)	O
Protocols	O
for	O
wound	O
management	O
.	O
Chronic	O
leg	SYMP
ulcers	SYMP
:	O
beware	O
the	O
'wolf	O
in	O
sheep	O
's	O
clothing	O
!	O
'	O
.	O
YES	O
YES	O
Evaluating	O
prostate	SYMP
needle	SYMP
biopsy	SYMP
:	O
therapeutic	O
and	O
prognostic	O
importance	O
.	O
Sudden	O
cryptococcal	SYMP
deafness	SYMP
.	O
Methicillin-resistant	O
Staphylococcus	O
aureus	O
clinical	O
strain	O
with	O
reduced	O
vancomycin	SYMP
susceptibility	O
.	O
HIV	O
and	O
AIDS	SYMP
awareness	O
:	O
an	O
evaluation	O
of	O
a	O
short	O
training	O
programme	O
for	O
midwives	O
.	O
What	O
investigations	O
and	O
procedures	O
do	O
patients	O
in	O
hospices	O
want	O
?	O
Interview	O
based	O
survey	O
of	O
patients	O
and	O
their	O
nurses	O
.	O
Occupational	O
asthma	SYMP
due	O
to	O
porcine	O
pancreatic	O
amylase	O
.	O
Double-blind	O
study	O
of	O
pulsing	SYMP
magnetic	SYMP
field	SYMP
effects	O
on	O
multiple	SYMP
sclerosis	SYMP
.	O
CDA	O
opposes	O
proposed	O
HBV	O
recommendations	O
.	O
The	O
influence	O
of	O
allergy	SYMP
and	O
smoking	O
on	O
the	O
sulphation	O
of	O
nasal	O
mucins	O
.	O
Clinical	O
problem-solving	O
.	O
A	O
hidden	O
agenda	O
.	O
A	O
comparison	O
of	O
the	O
early	O
outcome	O
of	O
acute	O
myocardial	SYMP
infarction	SYMP
in	O
women	O
and	O
men	O
.	O
The	O
Third	O
International	O
Study	O
of	O
Infarct	O
Survival	O
Collaborative	O
Group	O
.	O
Management	O
of	O
life-threatening	O
acid-base	SYMP
disorders	SYMP
.	O
Second	O
of	O
two	O
parts	O
.	O
TO_SEE	O
Removal	O
of	O
a	O
broken	O
solid-core	O
intramedullary	O
femoral	O
nail	O
using	O
both	O
antegrade	O
and	O
retrograde	O
starting	O
points	O
.	O
Do	O
no	O
harm	O
.	O
Thalidomide	SYMP
,	O
laser	O
cavity	O
preparation	O
and	O
oral	O
hydrogen	O
peroxide	O
.	O
Emergency	O
!	O
Meningococcal	SYMP
disease	SYMP
.	O
First	O
the	O
bad	O
news	O
...	O
.	O
Does	O
hyperglycemia	SYMP
really	O
cause	O
coronary	SYMP
heart	SYMP
disease	SYMP
?	O
[	O
Diagnosis	O
and	O
therapy	O
of	O
primary	O
stomach	SYMP
lymphoma	SYMP
.	O
Consensus	O
of	O
the	O
Surgical	O
Working	O
Group	O
for	O
Oncology	O
,	O
the	O
Working	O
Group	O
for	O
Medical	O
Oncology	O
and	O
the	O
Working	O
Group	O
for	O
Radiologic	O
Oncology	O
]	O
Rate	O
of	O
RhD	O
sensitisation	O
before	O
and	O
after	O
implementation	O
of	O
a	O
community	O
based	O
antenatal	O
prophylaxis	O
programme	O
.	O
Ovine	SYMP
Johne	SYMP
's	SYMP
disease	SYMP
.	O
Effect	O
of	O
HAART	O
on	O
natural	O
history	O
of	O
AIDS-related	SYMP
opportunistic	SYMP
disorders	SYMP
.	O
Psoas	SYMP
abscess	SYMP
.	O
Diagnosed	O
if	O
suspected	O
.	O
Breastfeeding	O
and	O
catch-up	O
growth	O
in	O
infants	O
born	O
small	O
for	O
gestational	O
age	O
.	O
Health	O
practices	O
of	O
critical	O
care	O
nurses	O
:	O
are	O
these	O
nurses	O
good	O
role	O
models	O
for	O
patients	O
?	O
Testing	O
for	O
Helicobacter	SYMP
pylori	SYMP
infection	SYMP
after	O
antibiotic	SYMP
treatment	SYMP
.	O
Bullous	O
eruption	O
in	O
a	O
patient	O
with	O
systemic	SYMP
lupus	SYMP
erythematosus	SYMP
:	O
mite	SYMP
dermatitis	SYMP
caused	O
by	O
Cheyletiella	O
blakei	O
.	O
A	O
case-control	O
study	O
of	O
cytochrome	O
P450	O
1A1	O
,	O
glutathione	O
S-transferase	O
M1	O
,	O
cigarette	O
smoking	O
and	O
lung	O
cancer	O
susceptibility	O
(	O
Massachusetts	O
,	O
United	O
States	O
)	O
Association	O
between	O
thrombolytic	SYMP
treatment	SYMP
and	O
the	O
prognosis	O
of	O
hemodynamically	O
stable	O
patients	O
with	O
major	SYMP
pulmonary	SYMP
embolism	SYMP
:	O
results	O
of	O
a	O
multicenter	O
registry	O
.	O
Metastatic	SYMP
malignant	SYMP
mesothelioma	SYMP
presenting	O
as	O
colonic	O
polyps	O
.	O
YES	O
A	O
positive	O
cannabinoids	O
workplace	O
drug	O
test	O
following	O
the	O
ingestion	O
of	O
commercially	O
available	O
hemp	O
seed	O
oil	O
.	O
Congenital	SYMP
diaphragmatic	SYMP
hernia	SYMP
:	O
what	O
happens	O
after	O
discharge	O
?	O
Goldilocks	O
and	O
Mrs.	O
Ilych	O
:	O
a	O
critical	O
look	O
at	O
the	O
``	O
philosophy	O
of	O
hospice	O
''	O
.	O
Sensitivity	O
and	O
specificity	O
of	O
the	O
neonatal	O
brain-stem	O
auditory	O
evoked	O
potential	O
for	O
hearing	O
and	O
language	O
deficits	O
in	O
survivors	O
of	O
extracorporeal	O
membrane	O
oxygenation	O
.	O
The	O
Federated	O
Council	O
of	O
Internal	O
Medicine	O
's	O
resource	O
guide	O
for	O
residency	O
education	O
:	O
an	O
instrument	O
for	O
curricular	O
change	O
.	O
A	O
reluctant	O
doctor	O
shopper	O
.	O
[	O
Frequent	O
users	O
of	O
emergency	O
services	O
]	O
Localized	O
Darier	SYMP
disease	SYMP
.	O
Implications	O
for	O
genetic	O
studies	O
.	O
YES	O
The	O
prison	O
patient	O
.	O
Fulminant	O
hepatic	SYMP
failure	SYMP
in	O
murine	SYMP
hepatitis	SYMP
virus	SYMP
strain	SYMP
3	SYMP
infection	SYMP
:	O
tissue-specific	O
expression	O
of	O
a	O
novel	O
fgl2	O
prothrombinase	O
.	O
YES	O
[	O
The	O
use	O
and	O
effects	O
of	O
postcoital	O
contraception	O
]	O
Vancomycin-resistant	O
Staphylococcus	O
aureus	O
:	O
apocalypse	O
now	O
?	O
Reflex	SYMP
sympathetic	SYMP
dystrophy	SYMP
:	O
fact	O
and	O
fiction	O
.	O
[	O
Acute	SYMP
hydrocephalus	SYMP
and	O
brain	SYMP
abscess	SYMP
in	O
Listeria	SYMP
monocytogenes	SYMP
meningitis	SYMP
]	O
Antisense	O
suppression	O
of	O
4-coumarate	O
:	O
coenzyme	O
A	O
ligase	O
activity	O
in	O
Arabidopsis	O
leads	O
to	O
altered	O
lignin	O
subunit	O
composition	O
.	O
TO_SEE	O
Implementation	O
of	O
pharmaceutical	O
practice	O
guidelines	O
.	O
In	O
vitro	O
interactions	O
of	O
oxidatively	O
modified	O
LDL	O
with	O
type	O
I	O
,	O
II	O
,	O
III	O
,	O
IV	O
,	O
and	O
V	O
collagen	O
,	O
laminin	O
,	O
fibronectin	O
,	O
and	O
poly-D-lysine	O
.	O
Factors	O
influencing	O
blood	O
flow	O
in	O
the	O
optic	O
nerve	O
head	O
.	O
Mutations	O
of	O
the	O
Drosophila	O
dDP	O
,	O
dE2F	O
,	O
and	O
cyclin	O
E	O
genes	O
reveal	O
distinct	O
roles	O
for	O
the	O
E2F-DP	O
transcription	O
factor	O
and	O
cyclin	O
E	O
during	O
the	O
G1-S	O
transition	O
.	O
SYT-SSX	O
gene	O
fusion	O
as	O
a	O
determinant	O
of	O
morphology	O
and	O
prognosis	O
in	O
synovial	O
sarcoma	O
.	O
A	O
rapid	O
molecular	O
method	O
(	O
polymerase	O
chain	O
reaction	O
with	O
sequence-specific	O
primers	O
)	O
to	O
genotype	O
for	O
ABO	O
blood	O
group	O
and	O
secretor	O
status	O
and	O
its	O
potential	O
for	O
organ	SYMP
transplants	SYMP
.	O
A	O
population-based	O
registry	O
on	O
paraproteinaemia	SYMP
in	O
The	O
Netherlands	O
.	O
Comprehensive	O
Cancer	O
Centre	O
West	O
,	O
Leiden	O
,	O
The	O
Netherlands	O
.	O
Intra-	O
and	O
inter-individual	O
biological	O
variability	O
data	O
bank	O
.	O
Genetic	O
testing	O
for	O
cancer	SYMP
risk	O
:	O
how	O
to	O
reconcile	O
the	O
conflicts	O
.	O
Run-in	O
periods	O
in	O
randomized	O
trials	O
:	O
implications	O
for	O
the	O
application	O
of	O
results	O
in	O
clinical	O
practice	O
.	O
Rapid	O
and	O
ultrarapid	O
opioid	SYMP
detoxification	SYMP
techniques	O
.	O
Fulminant	O
hepatitis	SYMP
associated	O
with	O
hepatitis	SYMP
A	SYMP
virus	SYMP
superinfection	SYMP
in	O
patients	O
with	O
chronic	O
hepatitis	SYMP
C	SYMP
.	O
The	O
Overactive	SYMP
Bladder	SYMP
:	O
From	O
Basic	O
Science	O
to	O
Clinical	O
Management	O
Consensus	O
Conference	O
.	O
Proceedings	O
.	O
London	O
,	O
England	O
,	O
June	O
29	O
,	O
1997	O
.	O
Techniques	O
for	O
erbium	SYMP
:	SYMP
YAG	SYMP
laser	SYMP
skin	SYMP
resurfacing	SYMP
:	O
initial	O
pearls	O
from	O
the	O
first	O
100	O
patients	O
.	O
Predicting	O
changes	O
in	O
the	O
distribution	O
of	O
sweating	SYMP
following	O
thoracoscopic	SYMP
sympathectomy	SYMP
.	O
The	O
AACC	O
Lectureship	O
Award	O
Address	O
.	O
The	O
market	O
for	O
health	O
care	O
:	O
where	O
is	O
the	O
patient	O
?	O
Human	O
fetal	O
pituitary	O
expresses	O
functional	O
growth	O
hormone-releasing	O
peptide	O
receptors	O
.	O
The	O
Bizarro	O
world	O
of	O
osteodistraction	SYMP
.	O
A	O
piece	O
of	O
my	O
mind	O
.	O
Leaders	O
or	O
lemmings	O
?	O
Sales	O
of	O
food	O
aid	O
as	O
sign	O
of	O
distress	O
,	O
not	O
excess	O
.	O
Gastrointestinal	O
absorption	O
of	O
metals	O
.	O
Embryonic	O
stem	O
cells	O
and	O
hematopoietic	O
stem	O
cell	O
biology	O
.	O
YES	O
The	O
role	O
of	O
the	O
school	O
in	O
the	O
management	O
of	O
attention	SYMP
deficit	SYMP
hyperactivity	SYMP
disorder	SYMP
.	O
Photorepair	O
mutants	O
of	O
Arabidopsis	O
.	O
Toxic	SYMP
shock	SYMP
syndrome	SYMP
without	O
rash	SYMP
in	O
a	O
young	O
child	O
:	O
link	O
with	O
syndrome	O
of	O
hemorrhagic	SYMP
shock	SYMP
and	O
encephalopathy	SYMP
?	O
Mediastinal	O
growing	O
teratoma	SYMP
syndrome	SYMP
.	O
Structure	O
and	O
expression	O
of	O
the	O
chicken	O
calmodulin	O
I	O
gene	O
.	O
Fibromyalgia	SYMP
--	O
out	O
of	O
control	O
?	O
Fibromyalgia	SYMP
:	O
La	O
Maladie	O
est	O
Morte	O
.	O
Vive	O
le	O
Malade	O
!	O
Electron	O
beam	O
computed	O
tomographic	O
coronary	O
calcium	O
as	O
a	O
predictor	O
of	O
coronary	O
events	O
:	O
comparison	O
of	O
two	O
protocols	O
.	O
The	O
ethics	O
of	O
genetic	O
research	O
on	O
sexual	O
orientation	O
.	O
YES	O
Cyclin	O
D1	O
overexpression	O
in	O
malignant	SYMP
lymphomas	SYMP
.	O
Patient	O
safety	O
and	O
scented	O
pediatric	O
anesthesia	O
facemasks	O
.	O
Ion	O
channels	O
.	O
SHARPs	O
:	O
mammalian	O
enhancer-of-split-	O
and	O
hairy-related	O
proteins	O
coupled	O
to	O
neuronal	O
stimulation	O
.	O
Complementary	O
and	O
alternative	O
medicine	O
:	O
friend	O
,	O
foe	O
,	O
or	O
OWA	O
?	O
[	O
Ondansetron	SYMP
is	O
not	O
a	O
panacea	O
]	O
Masking	O
,	O
blinding	O
,	O
and	O
peer	O
review	O
:	O
the	O
blind	O
leading	O
the	O
blinded	O
.	O
[	O
Human	O
cervico-facial	O
morphogenesis	O
.	O
Evaluation	O
of	O
acquired	O
data	O
and	O
current	O
outlook	O
.	O
(	O
Part	O
1	O
:	O
facial	O
morphogenesis	O
)	O
]	O
YES	O
Spontaneous	O
exfoliation	O
of	O
teeth	O
following	O
severe	O
elemental	O
mercury	SYMP
poisoning	SYMP
:	O
case	O
report	O
and	O
histological	O
investigation	O
for	O
mechanism	O
.	O
Small	SYMP
cell	SYMP
lung	SYMP
cancer	SYMP
can	O
express	O
CD34	O
antigen	O
.	O
X	O
inactivation	O
in	O
females	O
with	O
X-linked	SYMP
disease	SYMP
.	O
Report	O
of	O
spores	O
of	O
Henneguya	O
salminicola	O
(	O
Myxozoa	O
)	O
in	O
human	O
stool	O
specimens	O
:	O
possible	O
source	O
of	O
confusion	O
with	O
human	O
spermatozoa	O
.	O
Evaluation	O
of	O
a	O
ventilation	SYMP
strategy	SYMP
to	O
prevent	O
barotrauma	SYMP
in	O
patients	O
at	O
high	O
risk	O
for	O
acute	SYMP
respiratory	SYMP
distress	SYMP
syndrome	SYMP
.	O
Pressure-	O
and	O
Volume-Limited	O
Ventilation	O
Strategy	O
Group	O
.	O
Audit	O
commission	O
tackles	O
anaesthetic	O
services	O
.	O
Abdominal	SYMP
tuberculosis	SYMP
involving	O
hepatic	O
hilar	O
lymph	O
nodes	O
.	O
A	O
cause	O
of	O
portal	SYMP
vein	SYMP
thrombosis	SYMP
and	O
portal	SYMP
hypertension	SYMP
.	O
YES	O
Analgesic	SYMP
nephropathy	SYMP
.	O
Translocations	O
of	O
11q13	O
in	O
mantle	SYMP
cell	SYMP
lymphoma	SYMP
fail	O
to	O
disrupt	O
the	O
S	O
mu	O
bp-2	O
gene	O
.	O
Variation	O
in	O
proficiency	O
testing	O
performance	O
by	O
testing	O
site	O
.	O
The	SYMP
``	SYMP
H	SYMP
''	SYMP
graft	SYMP
:	O
an	O
alternative	O
approach	O
for	O
performing	O
minimally	O
invasive	O
direct	SYMP
coronary	SYMP
artery	SYMP
bypass	SYMP
.	O
Effect	O
of	O
interferon	SYMP
on	O
hepatitis	SYMP
B	SYMP
.	O
Health	O
insurance	O
for	O
children	O
--	O
a	O
model	O
for	O
incremental	O
health	O
reform	O
?	O
Distinction	O
awards	O
and	O
racial	O
discrimination	O
.	O
Potential	O
biases	O
were	O
not	O
taken	O
into	O
account	O
in	O
study	O
of	O
waiting	O
times	O
.	O
Factors	O
affecting	O
uptake	O
of	O
antenatal	O
HIV	O
testing	O
in	O
London	O
:	O
results	O
of	O
a	O
multicentre	O
study	O
.	O
Coronary	O
arterioluminal	O
communications	O
in	O
routine	O
angiography	O
.	O
Peptide	O
nucleic	O
acid	O
(	O
PNA	O
)	O
from	O
DNA	O
recognition	O
to	O
antisense	O
and	O
DNA	O
structure	O
.	O
YES	O
Treatment	O
of	O
postmenopausal	SYMP
osteoporosis	SYMP
.	O
Fascioloidiasis	SYMP
in	O
game-ranched	O
elk	O
from	O
Montana	O
.	O
Connexin-26	O
mutations	O
in	O
sporadic	O
non-syndromal	SYMP
sensorineural	SYMP
deafness	SYMP
.	O
Lyme	SYMP
disease	SYMP
presenting	O
as	O
Tourette	SYMP
's	SYMP
syndrome	SYMP
.	O
The	O
screening	O
muddle	O
.	O
Treatment	O
of	O
hypertensive	O
patients	O
with	O
diabetes	SYMP
.	O
China	O
's	O
human-organ	O
trade	O
highlighted	O
by	O
US	O
arrest	O
of	O
``	O
salesman	O
''	O
.	O
Dimension	O
in	O
defining	O
tumor	SYMP
response	O
.	O
Administration	O
of	O
dexamethasone	SYMP
induces	O
proteinuria	SYMP
of	O
glomerular	O
origin	O
in	O
mice	O
.	O
Preoperative	O
thromboxane	O
A2/prostaglandin	O
H2	O
receptor	O
activity	O
predicts	O
early	O
graft	SYMP
thrombosis	SYMP
.	O
Hypertension	SYMP
treatment	O
and	O
control	O
in	O
sub-Saharan	O
Africa	O
:	O
the	O
epidemiological	O
basis	O
for	O
policy	O
.	O
Needle-exchange	O
programmes	O
in	O
the	O
USA	O
.	O
A	O
discriminant	O
function	O
for	O
preeclampsia	SYMP
:	O
case-control	O
study	O
of	O
minor	O
hemoglobins	O
,	O
red	O
cell	O
enzymes	O
,	O
and	O
clinical	O
laboratory	O
values	O
.	O
Patterning	O
of	O
immobilized	O
antibody	O
layers	O
via	O
photolithography	O
and	O
oxygen	O
plasma	O
exposure	O
.	O
A	O
cell-based	O
immunobiosensor	O
with	O
engineered	O
molecular	O
recognition	O
--	O
Part	O
II	O
:	O
Enzyme	O
amplification	O
systems	O
.	O
Evanescent	O
wave	O
fibre	O
optic	O
sensor	O
for	O
detection	O
of	O
L.	O
donovani	O
specific	O
antibodies	O
in	O
sera	O
of	O
kala	O
azar	O
patients	O
.	O
Multianalyte	O
biosensors	O
on	O
optical	O
imaging	O
bundles	O
.	O
Specific	O
binding	O
of	O
low	O
molecular	O
weight	O
ligands	O
with	O
direct	O
optical	O
detection	O
.	O
Amperometric	O
lactate	O
oxidase	O
catheter	O
for	O
real-time	O
lactate	O
monitoring	O
based	O
on	O
thin	O
film	O
technology	O
.	O
Dual-fractal	O
analysis	O
for	O
antigen	O
--	O
antibody	O
binding	O
kinetics	O
for	O
biosensor	O
applications	O
.	O
Dipstick	O
only	O
urinalysis	O
screen	O
for	O
the	O
pediatric	O
emergency	O
room	O
.	O
Cytoplasmic	O
transport	O
in	O
Drosophila	O
ovarian	O
follicles	O
:	O
the	O
migration	O
of	O
microinjected	O
fluorescent	O
probes	O
through	O
intercellular	O
bridges	O
depends	O
neither	O
on	O
electrical	O
charge	O
nor	O
on	O
external	O
osmolarity	O
.	O
Further	O
evidence	O
for	O
the	O
importance	O
of	O
an	O
androgen	O
response	O
element	O
in	O
the	O
factor	O
IX	O
promoter	O
.	O
The	O
obstetric	O
experience	O
of	O
carriers	O
of	O
haemophilia	SYMP
.	O
Acquired	O
haemophilia	SYMP
,	O
an	O
unusual	O
cause	O
of	O
severe	O
postpartum	SYMP
haemorrhage	SYMP
.	O
Zoonotic	O
and	O
viral	SYMP
infection	SYMP
in	O
fetal	O
loss	O
after	O
12	O
weeks	O
.	O
High-affinity	O
binding	O
of	O
the	O
neonatal	O
Fc	O
receptor	O
to	O
its	O
IgG	O
ligand	O
requires	O
receptor	O
immobilization	O
.	O
Molecular	O
distances	O
from	O
dipolar	O
coupled	O
spin-labels	O
:	O
the	O
global	O
analysis	O
of	O
multifrequency	O
continuous	O
wave	O
electron	O
paramagnetic	O
resonance	O
data	O
.	O
Computer	O
science	O
and	O
biology	O
--	O
the	O
German	O
Conference	O
on	O
Bioinformatics	O
(	O
GCB'96	O
)	O
.	O
Surface	O
plasmon	O
resonance	O
analysis	O
of	O
topoisomerase	O
I-DNA	O
binding	O
:	O
effect	O
of	O
Mg2+	O
and	O
DNA	O
sequence	O
.	O
The	O
1996	O
list	O
.	O
Proposed	O
new	O
bacterial	O
taxa	O
and	O
proposed	O
changes	O
of	O
bacterial	O
names	O
published	O
during	O
1996	O
and	O
considered	O
to	O
be	O
of	O
interest	O
to	O
medical	O
or	O
veterinary	O
bacteriology	O
.	O
An	O
informational	O
note	O
.	O
The	O
1995	O
list	O
.	O
Proposed	O
new	O
bacterial	O
taxa	O
and	O
proposed	O
changes	O
of	O
bacterial	O
names	O
published	O
during	O
1995	O
and	O
considered	O
to	O
be	O
of	O
interest	O
to	O
medical	O
or	O
veterinary	O
bacteriology	O
.	O
An	O
informational	O
note	O
.	O
Biobehavioral	O
pain	SYMP
research	O
:	O
a	O
multi-institute	O
assessment	O
of	O
cross-cutting	O
issues	O
and	O
research	O
needs	O
.	O
Use	O
of	O
surface	O
plasmon	O
resonance	O
to	O
probe	O
the	O
equilibrium	O
and	O
dynamic	O
aspects	O
of	O
interactions	O
between	O
biological	O
macromolecules	O
.	O
ABC	O
of	O
mental	O
health	O
.	O
Psychosexual	SYMP
problems	SYMP
.	O
Hazards	O
of	O
running	O
a	O
marathon	O
.	O
Troponin-T	O
concentrations	O
should	O
be	O
measured	O
.	O
Second	O
Strang	O
International	O
Cancer	O
Conference	O
:	O
genetics	O
and	O
the	O
environment	O
New	O
York	O
,	O
USA	O
,	O
15-16	O
November	O
1996	O
.	O
Use	O
of	O
a	O
modified	O
version	O
of	O
the	O
Overt	O
Aggression	O
Scale	O
in	O
the	O
measurement	O
and	O
assessment	O
of	O
aggressive	O
behaviours	O
following	O
brain	SYMP
injury	SYMP
.	O
[	O
Ectopic	SYMP
pregnancy	SYMP
recurrence	O
:	O
role	O
of	O
gynecologic	O
,	O
obstetric	O
,	O
contraceptive	O
and	O
smoking	O
history	O
]	O
[	O
AIDS	O
:	O
a	O
world	O
,	O
a	O
desire	O
]	O
Urogynaecology	O
proceedings	O
of	O
the	O
joint	O
RCOG/BAUS	O
urogynaecology	O
meeting	O
.	O
19	O
September	O
1996	O
.	O
The	O
naming	O
of	O
a	O
syndrome	O
.	O
The	O
use	O
of	O
implantable	O
venous	O
access	O
devices	O
(	O
IVADs	O
)	O
in	O
children	O
with	O
hemophilia	SYMP
.	O
Nephrotic	SYMP
syndrome	SYMP
associated	O
with	O
hypocomplementemia	SYMP
in	O
a	O
4-year-old	O
boy	O
with	O
hemophilia	SYMP
B	SYMP
.	O
Growth	O
hormone	O
secretion	O
in	O
HIV-positive	O
versus	O
HIV-negative	O
hemophilic	O
males	O
with	O
abnormal	O
growth	O
and	O
pubertal	O
development	O
.	O
The	O
Hemophilia	O
Growth	O
and	O
Development	O
Study	O
.	O
Trends	O
in	O
HIV	O
counseling	O
and	O
testing	O
of	O
clients	O
attending	O
a	O
public	O
sexually	O
transmitted	O
disease	O
clinic	O
in	O
Portland	O
,	O
Oregon	O
,	O
1989-1995	O
.	O
Risk	O
factors	O
for	O
HIV-1	SYMP
infection	SYMP
among	O
pregnant	O
women	O
in	O
French	O
Guiana	O
.	O
Angiogenesis	O
in	O
inflammatory	SYMP
disease	SYMP
.	O
Epidemiology	O
and	O
association	O
with	O
extra-gastrointestinal	SYMP
diseases	SYMP
.	O
Extra-gastrointestinal	SYMP
diseases	SYMP
and	O
Helicobacter	O
pylori	O
.	O
Update	O
on	O
Helicobacter	O
pylori	O
research	O
.	O
Diagnosis	O
.	O
Uptake	O
on	O
Helicobacter	O
pylori	O
research	O
.	O
Pathogenesis	O
and	O
host	O
response	O
.	O
Update	O
on	O
Helicobacter	O
pylori	O
research	O
.	O
Malignancies	O
.	O
Update	O
on	O
Helicobacter	O
pylori	O
research	O
.	O
Dyspepsia	SYMP
.	O
Update	O
on	O
Helicobacter	O
pylori	O
research	O
.	O
Eradication	O
.	O
Sequence	O
analysis	O
of	O
the	O
36-kb	O
region	O
between	O
gntZ	O
and	O
trnY	O
genes	O
of	O
Bacillus	O
subtilis	O
genome	O
.	O
A	O
review	O
of	O
interferon	O
immunogenicity	O
.	O
Based	O
on	O
a	O
roundtable	O
workshop	O
held	O
in	O
London	O
,	O
United	O
Kingdom	O
,	O
9	O
February	O
1996	O
.	O
[	O
Histologic	O
diagnosis	O
of	O
chronic	SYMP
hepatitis	SYMP
,	O
grading	O
and	O
staging	O
]	O
YES	O
Current	O
progress	O
in	O
early	O
pregnancy	O
investigation	O
.	O
Truncated-gene	O
reporter	O
system	O
for	O
studying	O
the	O
regulation	O
of	O
manganese	O
peroxidase	O
expression	O
.	O
Disparate	O
sequence	O
characteristics	O
of	O
the	O
Erysiphe	O
graminis	O
f.sp	O
.	O
hordei	O
glyceraldehyde-3-phosphate	O
dehydrogenase	O
gene	O
.	O
The	O
Integrative	O
Neurobiology	O
of	O
Affiliation	O
.	O
Proceedings	O
of	O
a	O
conference	O
.	O
Washington	O
,	O
DC	O
,	O
USA	O
.	O
March	O
14-17	O
,	O
1996	O
.	O
Proceedings	O
of	O
the	O
10th	O
International	O
Symposium	O
on	O
the	O
Pharmacology	O
of	O
Thermoregulation	O
.	O
Memphis	O
,	O
Tennessee	O
,	O
USA	O
.	O
August	O
17-22	O
,	O
1996	O
.	O
Neuropeptides	O
in	O
Development	O
and	O
Aging	O
.	O
Proceedings	O
of	O
a	O
conference	O
.	O
Breckenridge	O
,	O
Colorado	O
,	O
USA	O
.	O
February	O
3-6	O
,	O
1996	O
.	O
Receptor	O
Classification	O
:	O
The	O
Integration	O
of	O
Operational	O
,	O
Structural	O
,	O
and	O
Transductional	O
Information	O
.	O
Proceedings	O
of	O
a	O
conference	O
.	O
Verona	O
,	O
Italy	O
,	O
September	O
21-22	O
,	O
1995	O
.	O
Psychobiology	O
of	O
Postraumatic	SYMP
Stress	SYMP
Disorder	SYMP
.	O
Proceedings	O
of	O
a	O
conference	O
.	O
New	O
York	O
,	O
New	O
York	O
,	O
USA	O
.	O
September	O
7-10	O
,	O
1996	O
.	O
Adolescent	O
Gynecology	O
and	O
Endocrinology	O
:	O
Basic	O
and	O
Clinical	O
Aspects	O
.	O
Proceedings	O
of	O
the	O
3rd	O
International	O
Congress	O
.	O
Athens	O
,	O
Greece	O
,	O
December	O
6-9	O
,	O
1995	O
.	O
Proceedings	O
of	O
the	O
3rd	O
International	O
Conference	O
on	O
Neuroprotective	O
Agents	O
:	O
Clinical	O
and	O
Experimental	O
Aspects	O
.	O
Lake	O
Como	O
,	O
Italy	O
,	O
September	O
9-12	O
,	O
1996	O
.	O
Exon/intron	O
structure	O
of	O
the	O
human	O
AF-4	O
gene	O
,	O
a	O
member	O
of	O
the	O
AF-4/LAF-4/FMR-2	O
gene	O
family	O
coding	O
for	O
a	O
nuclear	O
protein	O
with	O
structural	O
alterations	O
in	O
acute	O
leukaemia	SYMP
.	O
Cloning	O
and	O
characterization	O
of	O
a	O
neural	O
cell	O
recognition	O
molecule	O
on	O
axons	O
of	O
the	O
retinotectal	O
system	O
and	O
spinal	O
cord	O
.	O
Identification	O
,	O
localization	O
,	O
and	O
expression	O
of	O
two	O
novel	O
human	O
genes	O
similar	O
to	O
deoxyribonuclease	O
I	O
.	O
Drug	O
resistance	O
during	O
indinavir	SYMP
therapy	SYMP
is	O
caused	O
by	O
mutations	O
in	O
the	O
protease	O
gene	O
and	O
in	O
its	O
Gag	O
substrate	O
cleavage	O
sites	O
.	O
A	O
protein	O
with	O
a	O
novel	O
calcium-binding	O
domain	O
associated	O
with	O
calcareous	O
corpuscles	O
in	O
Echinococcus	SYMP
granulosus	SYMP
.	O
Oncogenic	O
raf-1	O
induces	O
the	O
expression	O
of	O
non-histone	O
chromosomal	O
architectural	O
protein	O
HMGI-C	O
via	O
a	O
p44/p42	O
mitogen-activated	O
protein	O
kinase-dependent	O
pathway	O
in	O
salivary	O
epithelial	O
cells	O
.	O
Pendred	SYMP
syndrome	SYMP
is	O
caused	O
by	O
mutations	O
in	O
a	O
putative	O
sulphate	O
transporter	O
gene	O
(	O
PDS	O
)	O
.	O
Meis2	O
,	O
a	O
novel	O
mouse	O
Pbx-related	O
homeobox	O
gene	O
induced	O
by	O
retinoic	O
acid	O
during	O
differentiation	O
of	O
P19	O
embryonal	O
carcinoma	O
cells	O
.	O
Proceedings	O
of	O
the	O
VIIIth	O
International	O
Conference	O
on	O
the	O
Na/K-ATPase	O
and	O
Related	O
Transport	O
ATPases	O
.	O
Mar	O
del	O
Plata	O
,	O
Argentina	O
,	O
August	O
26-30	O
,	O
1996	O
.	O
Targeted	O
development	O
of	O
microsatellite	O
markers	O
from	O
the	O
defined	O
region	O
of	O
bovine	O
chromosome	O
6q21-31	O
.	O
Genetic	O
population	O
structure	O
in	O
the	O
yellow	O
mongoose	O
,	O
Cynictis	O
penicillata	O
.	O
ETTIN	O
patterns	O
the	O
Arabidopsis	O
floral	O
meristem	O
and	O
reproductive	O
organs	O
.	O
Ancient	O
DNA	O
from	O
amber	O
fossil	O
bees	O
?	O
The	O
histone	O
H1	O
genes	O
of	O
the	O
dipteran	O
insect	O
,	O
Chironomus	O
thummi	O
,	O
fall	O
under	O
two	O
divergent	O
classes	O
and	O
encode	O
proteins	O
with	O
distinct	O
intranuclear	O
distribution	O
and	O
potentially	O
different	O
functions	O
.	O
Characterization	O
of	O
the	O
orf31-petG	O
gene	O
cluster	O
from	O
the	O
plastid	O
genome	O
of	O
Populus	O
deltoides	O
.	O
Xenopus	O
Pax-2	O
displays	O
multiple	O
splice	O
forms	O
during	O
embryogenesis	O
and	O
pronephric	O
kidney	O
development	O
.	O
International	O
Workshop	O
on	O
Bone	O
Research	O
in	O
Space	O
.	O
Tokyo	O
,	O
Japan	O
,	O
November	O
11-13	O
,	O
1996	O
.	O
Proceedings	O
.	O
Joint	O
meeting	O
of	O
the	O
Benelux	O
Society	O
for	O
Microcirculation	O
and	O
the	O
Gesellschaft	O
fÃ1/4r	O
Mikrozirkulation	O
e.V	O
.	O
Mainz	O
,	O
Germany	O
,	O
October	O
23-25	O
,	O
1997	O
.	O
Abstracts	O
.	O
[	O
3rd	O
Congress	O
of	O
the	O
French	O
Society	O
of	O
Blood	SYMP
Transfusion	SYMP
.	O
Marseille	O
,	O
France	O
,	O
28-30	O
April	O
1998	O
]	O
Central	O
and	O
East	O
European	O
Regional	O
INTERASMA	O
Conference	O
.	O
Budapest	O
,	O
Hungary	O
,	O
August	O
24-27	O
,	O
1997	O
.	O
Summary	O
of	O
symposium	O
,	O
antisense	O
oligonucleotides	O
:	O
strategies	O
and	O
successes	O
.	O
Sarasota	O
,	O
Florida	O
,	O
USA	O
.	O
April	O
21	O
,	O
1995	O
.	O
International	O
forensic	O
science	O
and	O
justice	O
.	O
Proceedings	O
of	O
the	O
6th	O
Congress	O
of	O
the	O
SociÃ	O
(	O
c	O
)	O
tÃ	O
(	O
c	O
)	O
de	O
Pharmaco-Toxicologie	O
Cellulaire	O
and	O
the	O
SociÃ	O
(	O
c	O
)	O
tÃ	O
(	O
c	O
)	O
FranÃ§aise	O
de	O
Toxicologie	O
GÃ	O
(	O
c	O
)	O
nÃ	O
(	O
c	O
)	O
tique	O
.	O
Paris	O
,	O
France	O
,	O
March	O
6-7	O
,	O
1997	O
.	O
The	O
Italian	O
Association	O
for	O
the	O
Study	O
of	O
Glaucoma	SYMP
.	O
Proceedings	O
of	O
the	O
12th	O
annual	O
general	O
meeting	O
.	O
Rapallo	O
,	O
Italy	O
,	O
14-15	O
March	O
1997	O
.	O
Report	O
of	O
the	O
61st	O
National	O
Scientific	O
Meeting	O
of	O
the	O
American	O
College	O
of	O
Rheumatology	O
,	O
Washington	O
DC	O
,	O
8-12	O
November	O
1997	O
.	O
[	O
Topical	O
dictionary	O
]	O
USAN	O
Council	O
.	O
List	O
No	O
.	O
404	O
.	O
New	O
names	O
.	O
Nagrestipen	O
.	O
Proposed	O
genetic	O
nomenclature	O
rules	O
for	O
Tetrahymena	O
thermophila	O
,	O
Paramecium	O
primaurelia	O
and	O
Paramecium	O
tetraurelia	O
.	O
The	O
Seventh	O
International	O
Meeting	O
on	O
Ciliate	O
Molecular	O
Biology	O
Genetics	O
Nomenclature	O
.	O
[	O
Joint	O
annual	O
session	O
of	O
the	O
North	O
German	O
Society	O
of	O
Radiology	O
and	O
the	O
Radiology	O
Society	O
of	O
Lower	O
Saxony	O
and	O
Sachsen	O
Anhalt	O
.	O
Kiel	O
,	O
20-21	O
February	O
1998	O
.	O
Abstracts	O
]	O
Neurone	O
development	O
and	O
death	O
,	O
from	O
a	O
cell	O
biologist	O
's	O
perspective	O
.	O
[	O
3rd	O
Neurotrauma/Polytrauma	O
Symposium	O
.	O
Cologne	O
,	O
Germany	O
,	O
March	O
14-15	O
,	O
1998	O
.	O
Abstracts	O
]	O
Neuroimmunomodulation	O
:	O
Molecular	O
Aspects	O
,	O
Integrative	O
Systems	O
,	O
and	O
Clinical	O
Advances	O
.	O
Proceedings	O
of	O
the	O
3rd	O
Congress	O
of	O
the	O
International	O
Society	O
of	O
NeuroImmunoModulation	O
(	O
ISNIM	O
)	O
.	O
Bethesda	O
,	O
Maryland	O
,	O
USA	O
.	O
November	O
13-15	O
,	O
1996	O
.	O
8th	O
European	O
Meeting	O
on	O
Dysmorphology	O
.	O
Strasbourg	O
,	O
France	O
,	O
3-6	O
September	O
1997	O
.	O
Abstracts	O
.	O
EU	O
Working	O
Group	O
on	O
Tobacco	O
and	O
Oral	O
Health	O
Consensus	O
Meeting	O
.	O
Copenhagen	O
,	O
23-26	O
October	O
1997	O
.	O
Abstracts	O
.	O
Presentations	O
from	O
the	O
2nd	O
NIH	O
Symposium	O
on	O
Therapeutic	O
Oligonucleotides	O
:	O
Targeting	O
Transcription	O
Factors	O
and	O
Signaling	O
Pathways	O
.	O
Bethesda	O
,	O
Maryland	O
,	O
USA	O
.	O
December	O
5	O
,	O
1997	O
.	O
Infectious	SYMP
diseases	SYMP
:	O
their	O
impact	O
on	O
dentistry	O
.	O
What	O
's	O
new	O
in	O
protein	O
folding	O
?	O
EMBO	O
workshop	O
:	O
protein	O
folding	O
and	O
misfolding	O
inside	O
and	O
outside	O
the	O
cell	O
.	O
Meeting	O
of	O
the	O
European	O
forum	O
of	O
nurses	O
.	O
17th	O
European	O
Workshop	O
on	O
the	O
Cell	O
Biology	O
of	O
Phagocytes	O
.	O
Catania	O
,	O
Italy	O
,	O
May	O
27-31	O
,	O
1998	O
.	O
Abstracts	O
.	O
Onset	O
of	O
the	O
preovulatory	O
luteinizing	O
hormone	O
surge	O
:	O
diurnal	O
timing	O
and	O
critical	O
follicular	O
prerequisites	O
.	O
Municipal	O
animal	O
control	O
ordinances	O
--	O
some	O
legal	O
issues	O
.	O
Psychosexual	O
care	O
in	O
a	O
multi-ethnic	O
society	O
.	O
Serologic	O
evidence	O
for	O
mother-to-child	O
transmission	O
of	O
Kaposi	SYMP
sarcoma-associated	SYMP
herpesvirus	SYMP
infection	SYMP
.	O
Brandon/Hill	O
selected	O
list	O
of	O
nursing	O
books	O
and	O
journals	O
.	O
Retraction	O
.	O
The	O
TSG101	O
tumor	O
susceptibility	O
gene	O
is	O
located	O
in	O
chromosome	O
11	O
band	O
p15	O
and	O
is	O
mutated	O
in	O
human	O
breast	SYMP
cancer	SYMP
.	O
An	O
omission	O
.	O
[	O
Indoor	O
pollution	O
and	O
health	O
]	O
[	O
Dioxins	O
:	O
current	O
knowledge	O
about	O
health	O
effects	O
]	O
[	O
Influence	O
of	O
environmental	O
factors	O
on	O
fertility	O
:	O
example	O
of	O
the	O
diminution	O
of	O
sperm	O
quality	O
]	O
[	O
New	O
developments	O
in	O
the	O
treatment	O
of	O
diabetes	SYMP
and	O
hyperlipidemias	SYMP
]	O
YES	O
YES	O
YES	O
Overtraining	O
and	O
recovery	O
.	O
A	O
conceptual	O
model	O
.	O
Saliva	O
composition	O
and	O
exercise	O
.	O
Lipid	O
metabolism	O
during	O
exercise	O
.	O
Golf	SYMP
injuries	SYMP
.	O
An	O
overview	O
.	O
Prevention	O
of	O
ankle	SYMP
injuries	SYMP
.	O
[	O
Academic	O
medicine	O
--	O
alternative	O
medicine	O
from	O
the	O
viewpoint	O
of	O
public	O
health	O
public	O
health	O
directors	O
]	O
[	O
Academic	O
medicine	O
and	O
complementary	O
medicine	O
--	O
campaign	O
for	O
the	O
truth	O
in	O
medical	O
theories	O
]	O
[	O
The	O
academic	O
medicine	O
--	O
alternative	O
medicine	O
tension	O
field	O
]	O
[	O
Are	O
academic	O
medicine-alternative	O
medicine	O
incompatible	O
,	O
compatible	O
,	O
complementary	O
?	O
]	O
[	O
Research	O
in	O
complementary	O
medicine	O
:	O
results	O
and	O
problems	O
]	O
[	O
Subcutaneous	SYMP
hematomas	SYMP
,	O
reduced	O
Quick	O
value	O
.	O
Factor	SYMP
VII	SYMP
deficiency	SYMP
]	O
[	O
Mononucleosis	SYMP
infectiosa	SYMP
(	O
Epstein-Barr	SYMP
virus	SYMP
infection	SYMP
]	O
[	O
Morphology	O
and	O
molecular	O
biology	O
of	O
malignant	O
soft	SYMP
tissue	SYMP
sarcomas	SYMP
]	O
[	O
Surgical	O
aspects	O
in	O
the	O
multidisciplinary	O
treatment	O
of	O
soft	SYMP
tissue	SYMP
sarcomas	SYMP
]	O
YES	O
YES	O
YES	O
[	O
Spinal	SYMP
muscular	SYMP
atrophy	SYMP
:	O
where	O
are	O
we	O
in	O
1998	O
?	O
]	O
[	O
Diseases	O
transmitted	O
by	O
non-conventional	O
agents	O
(	O
``	O
prions	O
''	O
)	O
:	O
nosology	O
and	O
diagnosis	O
]	O
[	O
A	O
note	O
on	O
the	O
epidemiology	O
of	O
Creutzfeldt-Jakob	SYMP
syndrome	SYMP
]	O
[	O
Biology	O
of	O
non-conventional	O
transmissible	O
agents	O
or	O
prions	O
]	O
[	O
Cerebral	SYMP
hemosiderosis	SYMP
related	O
to	O
hereditary	O
ceruloplasmin	SYMP
deficiency	SYMP
.	O
Clinical	O
familial	O
case	O
study	O
]	O
[	O
Intramedullary	O
metastases	O
of	O
bronchogenic	SYMP
carcinoma	SYMP
.	O
Two	O
cases	O
]	O
[	O
Nervous	SYMP
system	SYMP
borreliosis	SYMP
with	O
pseudo-lymphoma	O
cells	O
in	O
cerebrospinal	O
fluid	O
]	O
[	O
Epidural	O
and	O
intramedullary	O
abscess	O
of	O
acute	O
onset	O
]	O
[	O
Cranial	SYMP
nerve	SYMP
injuries	SYMP
during	O
multifocal	O
neuropathies	O
with	O
persistent	O
conduction	O
blocks	O
]	O
[	O
Cytokines	O
and	O
peripheral	O
neuropathies	O
]	O
[	O
Clinical	O
diagnosis	O
of	O
frontotemporal	SYMP
dementia	SYMP
]	O
[	O
Study	O
of	O
cortical	SYMP
atrophy	SYMP
with	O
magnetic	O
resonance	O
imaging	O
in	O
corticobasal	SYMP
degeneration	SYMP
]	O
[	O
Autosomal	O
dominant	O
nocturnal	O
frontal	O
lobe	O
epilepsy	SYMP
]	O
[	O
Eosinophilic	SYMP
meningitis	SYMP
due	O
to	O
Angiostrongylus	O
cantonensis	O
]	O
YES	O
[	O
Germinal	SYMP
tumor	SYMP
metastases	SYMP
.	O
Case	O
report	O
]	O
[	O
Bradycardia	SYMP
:	O
an	O
unrecognized	O
complication	O
of	O
some	O
epileptic	O
crises	O
]	O
(	O
Facial	SYMP
palsy	O
relevant	O
to	O
HIV	O
seropositivity	O
)	O
[	O
Pneumosinus	O
dilatans	O
:	O
a	O
little-known	O
diagnostic	O
tool	O
]	O
[	O
Current	O
status	O
of	O
mitochondrial	SYMP
diseases	SYMP
]	O
[	O
Vascular	SYMP
Parkinson	SYMP
syndromes	SYMP
:	O
a	O
controversial	O
concept	O
]	O
[	O
Epilepsy	SYMP
and	O
psychiatric	SYMP
disorders	SYMP
:	O
epidemiological	O
data	O
]	O
[	O
Auditory	SYMP
perception	SYMP
disorders	SYMP
due	O
to	O
bilateral	SYMP
cortical	SYMP
lesions	SYMP
.	O
An	O
electrophysiology	O
study	O
]	O
YES	O
Body	O
weight	O
and	O
mortality	O
among	O
women	O
.	O
Survey	O
and	O
assessment	O
of	O
the	O
actual	O
state	O
of	O
routine	O
measurement	O
of	O
glycohaemoglobin/GHb	O
by	O
commercial	O
methods	O
:	O
warning	O
to	O
the	O
users	O
and	O
the	O
providers	O
.	O
The	O
radiological	O
investigation	O
of	O
suspected	O
lower	O
limb	O
deep	SYMP
vein	SYMP
thrombosis	SYMP
.	O
p53	O
mutations	O
in	O
BRCA1-associated	O
familial	O
breast	SYMP
cancer	SYMP
.	O
[	O
Metronidazole	SYMP
(	O
Flagyl	O
)	O
]	O
The	O
Preterm	O
Prediction	O
Study	O
:	O
association	O
of	O
cesarean	SYMP
delivery	SYMP
with	O
increases	O
in	O
maternal	O
weight	O
and	O
body	O
mass	O
index	O
.	O
Controversies	O
in	O
hydrating	O
the	O
terminally	O
ill	O
patient	O
.	O
Frequency	O
and	O
significance	O
of	O
antinuclear	O
antibodies	O
in	O
multiple	SYMP
sclerosis	SYMP
.	O
Magnetic	O
resonance	O
imaging	O
of	O
the	O
bone	O
marrow	O
in	O
hematologic	SYMP
malignancies	SYMP
.	O
Generation	O
of	O
diversity	O
in	O
mammalian	O
gut-associated	O
lymphoid	O
tissues	O
:	O
restricted	O
V	O
gene	O
usage	O
does	O
not	O
preclude	O
complex	O
V	O
gene	O
organization	O
.	O
A	O
major	O
non-LTR	O
retrotransposon	O
of	O
Bombyx	O
mori	O
,	O
L1Bm	O
.	O
Algae	O
or	O
protozoa	O
:	O
phylogenetic	O
position	O
of	O
euglenophytes	O
and	O
dinoflagellates	O
as	O
inferred	O
from	O
mitochondrial	O
sequences	O
.	O
Structure	O
and	O
function	O
of	O
the	O
long	O
terminal	O
repeats	O
of	O
feline	O
leukemia	O
viruses	O
derived	O
from	O
naturally	O
occurring	O
acute	SYMP
myeloid	SYMP
leukemias	SYMP
in	O
cats	O
.	O
YES	O
Satellite	O
DNA	O
repeat	O
sequence	O
variation	O
is	O
low	O
in	O
three	O
species	O
of	O
burying	O
beetles	O
in	O
the	O
genus	O
Nicrophorus	O
(	O
Coleoptera	O
:	O
Silphidae	O
)	O
.	O
The	O
importance	O
of	O
patient	O
registration	O
and	O
processing	O
.	O
Dose-dependent	O
effects	O
of	O
recombinant	O
human	O
interleukin-6	O
on	O
glucose	O
regulation	O
.	O
Genomic	O
sequence	O
of	O
a	O
Lyme	SYMP
disease	SYMP
spirochaete	O
,	O
Borrelia	O
burgdorferi	O
.	O
Interaction	O
between	O
electronic	O
article	O
surveillance	O
systems	O
and	O
implantable	O
defibrillators	O
:	O
insights	O
from	O
a	O
fourth	O
generation	O
ICD	O
.	O
Human	O
bodily	O
health	O
and	O
the	O
common	O
good	O
.	O
Proposals	O
for	O
action	O
by	O
individuals	O
and	O
the	O
Catholic	O
Church	O
.	O
Invited	O
commentary	O
:	O
le	O
mystÃ¨re	O
de	O
MontrÃ	O
(	O
c	O
)	O
al	O
.	O
Why	O
Oedipus	O
and	O
not	O
Christ	O
?	O
:	O
a	O
psychoanalytic	O
inquiry	O
into	O
innocence	O
,	O
human	O
sacrifice	O
,	O
and	O
the	O
sacred	O
--	O
Part	O
I	O
:	O
Innocence	O
,	O
spirituality	O
,	O
and	O
human	O
sacrifice	O
.	O
Equine	O
dinucleotide	O
repeat	O
loci	O
LEX049-LEX063	O
.	O
Molecular	O
systematics	O
of	O
tanagers	O
(	O
Thraupinae	O
)	O
:	O
evolution	O
and	O
biogeography	O
of	O
a	O
diverse	O
radiation	O
of	O
neotropical	O
birds	O
.	O
Expression	O
of	O
cytokeratin	O
20	O
in	O
urinary	O
cytology	O
of	O
patients	O
with	O
bladder	SYMP
carcinoma	SYMP
.	O
A	O
family	O
of	O
highly	O
repetitive	O
DNAs	O
from	O
``	O
ginbuna	O
''	O
(	O
Carassius	O
auratus	O
langsdorfi	O
)	O
genome	O
common	O
to	O
Carassius	O
auratus	O
populations	O
.	O
Characterization	O
of	O
cDNA	O
clones	O
in	O
size-fractionated	O
cDNA	O
libraries	O
from	O
human	O
brain	O
.	O
TO_SEE	O
Mouse	O
LIM-kinase	O
2	O
gene	O
:	O
cDNA	O
cloning	O
,	O
genomic	O
organization	O
,	O
and	O
tissue-specific	O
expression	O
of	O
two	O
alternatively	O
initiated	O
transcripts	O
.	O
A	O
gross	O
and	O
microscopic	O
study	O
of	O
cerebral	SYMP
injuries	SYMP
accompanying	O
maxillofacial	O
high-velocity	O
projectile	SYMP
wounding	SYMP
in	O
dogs	O
.	O
Does	O
this	O
patient	O
have	O
a	O
mole	O
or	O
a	O
melanoma	SYMP
?	O
Methotrexate	SYMP
and	O
trimethoprim	SYMP
:	O
a	O
fatal	O
interaction	O
.	O
Pellagra	SYMP
and	O
the	O
origin	O
of	O
a	O
myth	O
:	O
evidence	O
from	O
European	O
literature	O
and	O
folklore	O
.	O
Absorbable	SYMP
suture	SYMP
technique	SYMP
:	O
solution	O
to	O
the	O
growth	O
problem	O
in	O
pediatric	O
pacing	O
with	O
endocardial	O
leads	O
.	O
Undergraduate	O
orthodontic	O
education	O
:	O
what	O
should	O
we	O
teach	O
rather	O
than	O
what	O
can	O
we	O
teach	O
?	O
Genetic	O
variation	O
in	O
the	O
dimorphic	O
regions	O
of	O
RAP-1	O
genes	O
and	O
rap-1	O
loci	O
of	O
Babesia	SYMP
bigemina	SYMP
.	O
[	O
History	O
--	O
a	O
living	O
museum	O
.	O
Interview	O
by	O
Grethe	O
Kjaergaard	O
.	O
]	O
[	O
Gastric	O
site	O
of	O
epidermoid	SYMP
carcinoma	SYMP
]	O
Hypodermic	O
needles	O
in	O
the	O
neuropathic	O
foot	O
of	O
a	O
patient	O
with	O
diabetes	SYMP
.	O
Helicobacter	O
pylori	O
--	O
more	O
light	O
,	O
less	O
heat	O
.	O
A	O
national	O
survey	O
of	O
physician-assisted	O
suicide	O
and	O
euthanasia	O
in	O
the	O
United	O
States	O
.	O
Death	O
is	O
a	O
journey	O
to	O
be	O
undertaken	O
.	O
Replicated	O
declines	O
in	O
assault	O
rates	O
after	O
implementation	O
of	O
the	O
Assaulted	O
Staff	O
Action	O
Program	O
.	O
Positive	O
patch	O
test	O
to	O
cocamidopropyl	O
betaine	O
in	O
a	O
hairdresser	O
.	O
Management	O
of	O
dyslipidemia	SYMP
in	O
adults	O
with	O
diabetes	SYMP
.	O
American	O
Diabetes	O
Association	O
.	O
Acute	SYMP
diverticulitis	SYMP
.	O
Investigation	O
of	O
the	O
yeast	O
mitochondrial	O
unselective	O
channel	O
in	O
intact	O
and	O
permeabilized	O
spheroplasts	O
.	O
Acute	SYMP
sciatica	SYMP
with	O
an	O
infective	O
cause	O
.	O
An	O
ecologic	O
analysis	O
of	O
psychosocial	SYMP
stress	SYMP
and	O
heart	SYMP
disease	SYMP
in	O
British	O
Columbia	O
.	O
Human	O
leukocyte	O
antigen	O
frequencies	O
in	O
a	O
selected	O
group	O
of	O
Lebanese	O
Greek	O
Orthodox	O
.	O
Alcohol	O
and	O
the	O
heart	O
.	O
Spontaneous	SYMP
ovarian	SYMP
hyperstimulation	SYMP
syndrome	SYMP
with	O
pregnancy	O
.	O
Will	O
the	O
real	O
plastic	O
surgeon	O
please	O
stand	O
up	O
?	O
YES	O
A	O
survey	O
of	O
the	O
attitudes	O
of	O
chronic	O
psychiatric	O
patients	O
living	O
in	O
the	O
community	O
toward	O
their	O
medication	O
.	O
Alterations	O
in	O
the	O
developing	O
immune	O
system	O
of	O
the	O
F344	O
rat	O
after	O
perinatal	O
exposure	O
to	O
2,3,7,8-tetrachlorodibenzo-p-dioxin	O
:	O
II	O
.	O
Effects	O
on	O
the	O
pup	O
and	O
the	O
adult	O
.	O
Renal	O
ultrasonography	O
:	O
a	O
procedure	O
for	O
nephrologists	O
.	O
YES	O
Bilateral	O
sampling	O
of	O
the	O
internal	O
jugular	O
vein	O
to	O
distinguish	O
between	O
mechanisms	O
of	O
adrenocorticotropic	O
hormone-dependent	O
Cushing	SYMP
syndrome	SYMP
.	O
The	O
influence	O
of	O
patients	O
'	O
hopes	O
of	O
receiving	O
a	O
prescription	O
on	O
doctors	O
'	O
perceptions	O
and	O
the	O
decision	O
to	O
prescribe	O
:	O
a	O
questionnaire	O
survey	O
.	O
Coronary	SYMP
endothelial	SYMP
dysfunction	SYMP
in	O
humans	O
is	O
associated	O
with	O
myocardial	SYMP
perfusion	SYMP
defects	SYMP
.	O
Medical	O
devices	O
and	O
the	O
year	O
2000	O
problem	O
.	O
Internists	O
'	O
and	O
surgeons	O
'	O
attitudes	O
toward	O
guns	O
and	O
firearm	O
injury	O
prevention	O
.	O
Firearm	O
injury	O
prevention	O
.	O
American	O
College	O
of	O
Physicians	O
.	O
Management	O
of	O
vaginal	SYMP
vault	SYMP
prolapse	SYMP
.	O
Death	O
rates	O
of	O
characters	O
in	O
soap	O
operas	O
on	O
British	O
television	O
:	O
is	O
a	O
government	O
health	O
warning	O
required	O
?	O
Child	O
sexual	O
abuse	O
:	O
when	O
a	O
doctor	O
's	O
duty	O
to	O
report	O
abuse	O
conflicts	O
with	O
a	O
duty	O
of	O
confidentiality	O
to	O
the	O
victim	O
.	O
Tissue	O
adhesives	O
--	O
revisited	O
.	O
Racial	O
discrimination	O
in	O
the	O
allocation	O
of	O
distinction	O
awards	O
?	O
Analysis	O
of	O
list	O
of	O
award	O
holders	O
by	O
type	O
of	O
award	O
,	O
specialty	O
and	O
region	O
.	O
YES	O
Consultation	O
section	O
.	O
Cataract	SYMP
surgical	O
problem	O
.	O
Changing	O
the	O
law	O
on	O
decision	O
making	O
for	O
mentally	O
incapacitated	O
adults	O
.	O
The	O
coding	O
audit	O
.	O
Providing	O
primary	O
care	O
in	O
the	O
accident	O
and	O
emergency	O
department	O
.	O
Challenges	O
to	O
Native	O
American	O
health	O
care	O
.	O
Federal	O
programs	O
and	O
Indian	O
country	O
:	O
a	O
time	O
for	O
reinvention	O
.	O
Chicago	O
report	O
profiles	O
.	O
Big	O
city	O
health	O
.	O
College-age	O
drinking	O
problems	O
.	O
Using	O
YPLL	O
in	O
health	O
planning	O
.	O
WHO	O
decides	O
:	O
food	O
irradiation	O
safe	O
at	O
any	O
level	O
.	O
Genetic	O
sampling	O
:	O
big	O
brother	O
or	O
big	O
science	O
?	O
Physician	O
assistants	O
and	O
nurse	O
practitioners	O
in	O
hospital	O
outpatient	O
departments	O
,	O
1993-1994	O
.	O
Laying	O
the	O
foundation	O
for	O
Healthy	O
People	O
2010	O
.	O
The	O
first	O
year	O
of	O
consultation	O
.	O
The	O
veracious	O
etiology	O
of	O
ectopic	SYMP
pregnancy	SYMP
.	O
Is	O
dietary	O
fat	O
a	O
major	O
determinant	O
of	O
body	O
fat	O
?	O
Factors	O
involved	O
in	O
the	O
rate	O
of	O
fall	O
of	O
thyroid	O
stimulating	O
hormone	O
in	O
treated	O
hypothyroidism	SYMP
.	O
Case	O
complexity	O
.	O
Imaging	O
pulmonary	SYMP
embolism	SYMP
.	O
Early	O
inpatient	O
rehabilitation	O
after	O
elective	O
hip	O
and	O
knee	O
arthroplasty	SYMP
.	O
Inpatient	O
rehabilitation	O
after	O
total	O
joint	SYMP
replacement	SYMP
.	O
Delayed	O
healing	O
of	O
rhytidectomy	SYMP
flap	O
resurfaced	O
with	O
CO2	O
laser	O
.	O
The	O
SAPHO	SYMP
syndrome	SYMP
:	O
an	O
evolving	O
concept	O
for	O
unifying	O
several	O
idiopathic	O
disorders	O
of	O
bone	O
and	O
skin	O
.	O
Beverage	O
use	O
and	O
risk	O
for	O
kidney	SYMP
stones	SYMP
in	O
women	O
.	O
Use	O
of	O
a	O
Foley	O
catheter	O
in	O
the	O
removal	O
of	O
a	O
substernal	SYMP
goiter	SYMP
.	O
Early	O
identification	O
of	O
variant	O
Creutzfeldt-Jakob	SYMP
disease	SYMP
.	O
Slater	O
revisited	O
:	O
6	O
year	O
follow	O
up	O
study	O
of	O
patients	O
with	O
medically	O
unexplained	O
motor	SYMP
symptoms	SYMP
.	O
Re	O
:	O
Intermediate	O
term	O
assessment	O
of	O
the	O
reliability	O
,	O
function	O
and	O
patient	O
satisfaction	O
with	O
the	O
AMS700	O
ultrex	O
penile	O
prosthesis	O
.	O
Reduced	O
ratio	O
of	O
male	O
to	O
female	O
births	O
in	O
several	O
industrial	O
countries	O
:	O
a	O
sentinel	O
health	O
indicator	O
?	O
Should	O
we	O
accept	O
mediocrity	O
?	O
YES	O
Colonoscopic	O
removal	O
of	O
chicken	O
bones	O
impacted	O
in	O
the	O
sigmoid	O
in	O
two	O
patients	O
.	O
``	O
Pull	O
''	O
or	O
``	O
push	O
''	O
PEG	O
:	O
the	O
reinsertion	O
of	O
the	O
gastroscope	O
is	O
often	O
unnecessary	O
.	O
Clear	SYMP
cell	SYMP
papulosis	SYMP
:	O
case	O
report	O
and	O
literature	O
review	O
.	O
Malignant	SYMP
melanoma	SYMP
in	O
situ	O
:	O
an	O
oxymoron	O
whose	O
time	O
has	O
come	O
.	O
YES	O
Somatic	O
mesoderm	O
differentiation	O
and	O
the	O
development	O
of	O
a	O
subset	O
of	O
pericardial	O
cells	O
depend	O
on	O
the	O
not	O
enough	O
muscles	O
(	O
nem	O
)	O
locus	O
,	O
which	O
contains	O
the	O
inscuteable	O
gene	O
and	O
the	O
intron	O
located	O
gene	O
,	O
skittles	O
.	O
Hemodynamic	O
effects	O
of	O
acute	O
tetrandrine	O
and	O
terlipressin	O
administration	O
on	O
portal	O
hypertensive	O
rats	O
.	O
Nonneoplastic	SYMP
disorders	SYMP
of	SYMP
the	SYMP
eccrine	SYMP
glands	SYMP
.	O
Cerebrospinal	O
fluid	O
and	O
plasma	O
insulin	O
levels	O
in	O
Alzheimer	SYMP
's	SYMP
disease	SYMP
:	O
relationship	O
to	O
severity	O
of	O
dementia	SYMP
and	O
apolipoprotein	O
E	O
genotype	O
.	O
Isolated	O
internal	SYMP
ophthalmoplegia	SYMP
associated	O
with	O
IgG	O
anti-GQ1b	O
antibody	O
.	O
YES	O
Enthesopathy	SYMP
in	O
a	O
case	O
of	O
primary	SYMP
biliary	SYMP
cirrhosis	SYMP
with	O
positive	O
HLA-B27	O
.	O
Remifentanil	SYMP
in	O
the	O
critically	O
ill	O
.	O
Hyponatremia	SYMP
with	O
venlafaxine	SYMP
.	O
YES	O
YES	O
Micronutrients	SYMP
and	O
human	O
cancer	SYMP
risks	SYMP
--	O
prospects	O
for	O
prevention	O
.	O
Joint	O
International	O
Symposium	O
of	O
the	O
Danish	O
Cancer	O
Society	O
,	O
European	O
Cancer	O
Prevention	O
Organization	O
and	O
National	O
Food	O
Agency	O
of	O
Denmark	O
.	O
Aarhus	O
,	O
Denmark	O
,	O
21-24	O
May	O
1997	O
.	O
Abstracts	O
.	O
Vitamin	O
K2	O
and	O
serum	O
cholesterol	O
in	O
patients	O
on	O
continuous	O
ambulatory	O
peritoneal	SYMP
dialysis	SYMP
.	O
Income	O
inequality	O
and	O
population	O
health	O
.	O
Naloxone	SYMP
-precipitated	O
acute	SYMP
opioid	SYMP
withdrawal	SYMP
syndrome	SYMP
after	O
epidural	SYMP
morphine	SYMP
.	O
[	O
Idiopathic	SYMP
atrial	SYMP
flutter	SYMP
]	O
Munchausen	SYMP
's	SYMP
syndrome	SYMP
.	O
YES	O
YES	O
Development	O
of	O
neurosurgery	SYMP
in	O
Greece	O
:	O
past	O
,	O
present	O
,	O
and	O
future	O
.	O
Intravascular-catheter-related	SYMP
infections	SYMP
.	O
The	O
effect	O
of	O
a	O
social	O
support	O
boosting	O
intervention	O
on	O
stress	O
,	O
coping	O
,	O
and	O
social	O
support	O
in	O
caregivers	O
of	O
children	O
with	O
HIV/AIDS	SYMP
.	O
Point-counterpoint	O
.	O
Mass	O
population	O
skin	SYMP
cancer	SYMP
screening	O
is	O
not	O
worthwhile	O
.	O
Persons	O
successful	O
at	O
long-term	O
weight	O
loss	O
and	O
maintenance	O
continue	O
to	O
consume	O
a	O
low-energy	O
,	O
low-fat	O
diet	O
.	O
Ultrasound	O
measurements	O
of	O
the	O
newborn	O
hip	O
.	O
Comparison	O
of	O
two	O
methods	O
in	O
657	O
newborns	O
.	O
Inferences	O
from	O
symphysiotomy	SYMP
experience	O
.	O
1995	O
coronary	SYMP
artery	SYMP
bypass	SYMP
risk	O
model	O
:	O
The	O
Society	O
of	O
Thoracic	O
Surgeons	O
Adult	O
Cardiac	O
National	O
Database	O
.	O
Informed	O
consent	O
:	O
edging	O
forwards	O
(	O
and	O
backwards	O
)	O
Online	O
medical	O
surveys	O
:	O
using	O
the	O
Internet	O
as	O
a	O
research	O
tool	O
.	O
US-guided	O
puncture	O
of	O
the	O
internal	O
jugular	O
vein	O
:	O
complications	O
and	O
anatomic	O
considerations	O
.	O
YES	O
The	O
effect	O
of	O
melatonin	O
administration	O
on	O
ethanol-induced	O
lipid	O
peroxidation	O
in	O
rats	O
.	O
YES	O
Mike	O
Grace	O
talks	O
to	O
Mike	O
Joy	O
.	O
Interview	O
by	O
Mike	O
Grace	O
.	O
Multivalent	O
cations	O
depress	O
ligand	O
affinity	O
of	O
insulin-like	O
growth	O
factor-binding	O
proteins-3	O
and	O
-5	O
on	O
human	O
GM-10	O
fibroblast	O
cell	O
surfaces	O
.	O
Effect	O
of	O
continuous	O
spinal	O
remifentanil	O
infusion	O
on	O
behaviour	O
and	O
spinal	O
glutamate	O
release	O
evoked	O
by	O
subcutaneous	O
formalin	O
in	O
the	O
rat	O
.	O
How	O
long	O
should	O
suction	O
drains	O
stay	O
in	O
after	O
breast	SYMP
surgery	SYMP
with	O
axillary	SYMP
dissection	SYMP
?	O
Physicians	O
disciplined	O
for	O
sex-related	O
offenses	O
.	O
Something	O
from	O
nothing	O
:	O
the	O
evolution	O
and	O
utility	O
of	O
satellite	O
repeats	O
.	O
Sudden	O
death	O
in	O
young	O
athletes	O
:	O
screening	O
for	O
the	O
needle	O
in	O
a	O
haystack	O
.	O
YES	O
TO_SEE	O
HIV	SYMP
vaccines	SYMP
:	O
prospects	O
and	O
challenges	O
.	O
Occupation	O
:	O
the	O
keystone	O
of	O
a	O
curriculum	O
for	O
a	O
self-defined	O
profession	O
.	O
Touch	O
sensibility	O
in	O
the	O
breast	O
after	O
subcutaneous	SYMP
mastectomy	SYMP
and	O
immediate	O
reconstruction	O
with	O
a	O
prosthesis	O
.	O
Iatrogenic	SYMP
ruptures	SYMP
of	O
the	O
tracheobronchial	O
tree	O
.	O
YES	O
Classification	O
of	O
primary	O
gastric	SYMP
lymphomas	SYMP
according	O
to	O
histologic	O
features	O
.	O
SCIM	O
--	O
spinal	O
cord	O
independence	O
measure	O
:	O
a	O
new	O
disability	O
scale	O
for	O
patients	O
with	O
spinal	SYMP
cord	SYMP
lesions	SYMP
.	O
Molecular	O
analysis	O
of	O
cellulose	O
biosynthesis	O
in	O
Arabidopsis	O
.	O
Users	O
'	O
guides	O
to	O
the	O
medical	O
literature	O
:	O
XIV	O
.	O
How	O
to	O
decide	O
on	O
the	O
applicability	O
of	O
clinical	O
trial	O
results	O
to	O
your	O
patient	O
.	O
Evidence-Based	O
Medicine	O
Working	O
Group	O
.	O
Hemispheric	O
difference	O
in	O
human	O
skin	O
color	O
.	O
Limitations	O
of	O
diagnostic	O
criteria	O
and	O
assessment	O
instruments	O
for	O
mental	SYMP
disorders	SYMP
.	O
Implications	O
for	O
research	O
and	O
policy	O
.	O
Causing	O
death	O
or	O
allowing	O
to	O
die	O
?	O
Developments	O
in	O
the	O
law	O
.	O
Albumin	O
synthesis	O
rates	O
are	O
not	O
decreased	O
in	O
hypoalbuminemic	SYMP
cachectic	SYMP
cancer	SYMP
patients	O
with	O
an	O
ongoing	O
acute-phase	O
protein	O
response	O
.	O
Brain-gut	O
axis	O
in	O
health	O
and	O
disease	O
.	O
Pins	O
and	O
Rubbers	O
Traction	O
System	O
.	O
A	O
specialist	O
nurse	O
can	O
replace	O
pre-registration	O
house	O
officers	O
in	O
the	O
surgical	O
pre-admission	O
clinic	O
.	O
Voluntary	O
death	O
:	O
a	O
comparison	O
of	O
terminal	O
dehydration	SYMP
and	O
physician-assisted	O
suicide	O
.	O
Ionized	O
magnesium	O
in	O
serum	O
and	O
ultrafiltrate	O
:	O
pH	O
and	O
bicarbonate	O
effect	O
on	O
measurements	O
with	O
the	O
AVL	O
988-4	O
electrolyte	O
analyzer	O
.	O
Anterior	SYMP
glenohumeral	SYMP
dislocations	SYMP
:	O
what	O
to	O
do	O
and	O
how	O
to	O
do	O
it	O
.	O
Relationship	O
between	O
topotecan	SYMP
systemic	O
exposure	O
and	O
tumor	O
response	O
in	O
human	O
neuroblastoma	SYMP
xenografts	SYMP
.	O
Cerebral	SYMP
infarct	SYMP
following	O
central	SYMP
venous	SYMP
cannulation	SYMP
The	O
Gram	O
stain	O
.	O
Heavy	O
caffeine	O
intake	O
in	O
pregnancy	O
and	O
sudden	SYMP
infant	SYMP
death	SYMP
syndrome	SYMP
.	O
New	O
Zealand	O
Cot	O
Death	O
Study	O
Group	O
.	O
When	O
can	O
odds	O
ratios	O
mislead	O
?	O
YES	O
Enzyme	O
structure	O
with	O
two	O
catalytic	O
sites	O
for	O
double-sieve	O
selection	O
of	O
substrate	O
.	O
Role	O
of	O
the	O
ketogenic	SYMP
diet	SYMP
in	O
children	O
with	O
intractable	SYMP
seizures	SYMP
.	O
Building-associated	O
pulmonary	SYMP
disease	SYMP
from	O
exposure	O
to	O
Stachybotrys	O
chartarum	O
and	O
Aspergillus	O
versicolor	O
.	O
Interleukin-8	O
participates	O
in	O
angiogenesis	O
in	O
non-small	O
cell	O
,	O
but	O
not	O
small	O
cell	O
carcinoma	SYMP
of	O
the	O
lung	O
.	O
Antenatal	SYMP
indomethacin	SYMP
--	O
adverse	O
fetal	O
effects	O
confirmed	O
.	O
Evaluation	O
of	O
the	O
microparticle	O
enzyme	O
immunoassay	O
Abbott	O
IMx	O
Select	O
Chlamydia	O
and	O
the	O
importance	O
of	O
urethral	O
site	O
sampling	O
to	O
detect	O
Chlamydia	SYMP
trachomatis	SYMP
in	O
women	O
.	O
The	O
persistent	O
vegetative	O
state	O
after	O
closed	SYMP
head	SYMP
injury	SYMP
:	O
clinical	O
and	O
magnetic	O
resonance	O
imaging	O
findings	O
in	O
42	O
patients	O
.	O
Wegener	SYMP
's	SYMP
granulomatosis	SYMP
of	O
the	O
head	O
and	O
neck	O
.	O
Chromosomal	O
abnormalities	O
of	O
a	O
new	O
nasopharyngeal	SYMP
carcinoma	SYMP
cell	O
line	O
(	O
NPC-BM1	O
)	O
derived	O
from	O
a	O
bone	SYMP
marrow	SYMP
metastatic	SYMP
lesion	SYMP
.	O
Relation	O
between	O
intellectual	SYMP
dysfunctioning	SYMP
and	O
mortality	O
in	O
community-residing	O
older	O
people	O
.	O
Anxiety	O
and	O
autonomic	O
flexibility	O
:	O
a	O
cardiovascular	O
approach	O
.	O
Cross-reactivity	O
of	O
specific	O
antibodies	O
directed	O
to	O
heat	O
shock	O
proteins	O
from	O
periodontopathogenic	O
bacteria	O
and	O
of	O
human	O
origin	O
[	O
corrected	O
]	O
Immunogenicity	O
of	O
hepatitis	SYMP
B	SYMP
vaccine	SYMP
in	O
term	O
and	O
preterm	O
infants	O
.	O
Secondary	O
prevention	O
for	O
stroke	SYMP
after	O
CAPRIE	SYMP
and	SYMP
ESPS-2	SYMP
.	O
TO_SEE	O
Magnetic	O
resonance	O
imaging	O
in	O
focal	SYMP
myositis	SYMP
.	O
Concomitant	SYMP
alveolitis	SYMP
and	O
asthma	SYMP
following	O
exposure	O
to	O
triphenylmethane	O
triisocyanate	O
.	O
Gorlin	SYMP
syndrome	SYMP
:	O
identification	O
of	O
4	O
novel	O
germ-line	O
mutations	O
of	O
the	O
human	O
patched	O
(	O
PTCH	O
)	O
gene	O
.	O
Mutations	O
in	O
brief	O
no	O
.	O
137	O
.	O
Online	O
.	O
Genetic	O
findings	O
in	O
congenital	SYMP
bilateral	SYMP
aplasia	SYMP
of	O
vas	O
deferens	O
patients	O
and	O
identification	O
of	O
six	O
novel	O
mutatations	O
.	O
Mutations	O
in	O
brief	O
no	O
.	O
138	O
.	O
Online	O
.	O
A	O
novel	O
point	O
mutation	O
in	O
a	O
splice	O
acceptor	O
site	O
of	O
intron	O
1	O
of	O
the	O
human	O
low	O
density	O
lipoprotein	O
receptor	O
gene	O
which	O
causes	O
severe	O
hypercholesterolemia	SYMP
:	O
an	O
unexpected	O
absence	O
of	O
exon	O
skipping	O
.	O
Mutations	O
in	O
brief	O
no	O
.	O
139	O
.	O
Online	O
.	O
A	O
de	O
novo	O
missense	O
mutation	O
(	O
R1623Q	O
)	O
of	O
the	O
SCN5A	O
gene	O
in	O
a	O
Japanese	O
girl	O
with	O
sporadic	SYMP
long	SYMP
QT	SYMP
sydrome	SYMP
.	O
Mutations	O
in	O
brief	O
no	O
.	O
140	O
.	O
Online	O
.	O
Missense	O
mutation	O
in	O
exon	O
11	O
(	O
Codon	O
378	O
)	O
of	O
the	O
presenilin-1	O
gene	O
in	O
a	O
French	O
family	O
with	O
early-onset	O
Alzheimer	SYMP
's	SYMP
disease	SYMP
and	O
transmission	O
study	O
by	O
mismatch	O
enhanced	O
allele	O
specific	O
amplification	O
.	O
Mutations	O
in	O
brief	O
no	O
.	O
141	O
.	O
Online	O
.	O
besancon	O
@	O
rockefeller1.univ.lyon1.fr	O
.	O
Mutation	O
sharing	O
,	O
predominant	O
involvement	O
of	O
the	O
MLH1	O
gene	O
and	O
description	O
of	O
four	O
novel	O
mutations	O
in	O
hereditary	SYMP
nonpolyposis	SYMP
colorectal	SYMP
cancer	SYMP
.	O
Mutations	O
in	O
brief	O
no	O
.	O
144	O
.	O
Online	O
.	O
A	O
new	O
informative	O
Alw	O
26	O
I	O
polymorphism	O
in	O
exon	O
10	O
of	O
the	O
human	O
low	O
density	O
lipoprotein	O
receptor	O
gene	O
.	O
Application	O
to	O
prenatal	O
diagnosis	O
.	O
Mutations	O
in	O
brief	O
no	O
.	O
145	O
.	O
Online	O
.	O
Novel	O
acceptor	O
splice	O
site	O
mutation	O
in	O
the	O
invariant	O
AG	O
of	O
intron	O
6	O
of	O
alpha-galactosidase	O
A	O
gene	O
,	O
causing	O
Fabry	SYMP
disease	SYMP
.	O
Mutations	O
in	O
brief	O
no	O
.	O
146	O
.	O
Online	O
.	O
Meta-analysis	O
of	O
trials	O
comparing	O
antidepressants	SYMP
with	O
active	O
placebos	O
.	O
Evidence-based	O
guidelines	O
for	O
universal	O
counselling	O
and	O
offering	O
of	O
HIV	O
testing	O
in	O
pregnancy	O
in	O
Canada	O
.	O
YES	O
TO_SEE	O
Simultaneous	O
microsurgical	SYMP
vasal	SYMP
reconstruction	SYMP
and	O
varicocele	SYMP
ligation	SYMP
:	O
safety	O
profile	O
and	O
outcomes	O
.	O
A	O
predetermined	O
design	O
for	O
easier	O
aesthetic	SYMP
abdominoplasty	SYMP
.	O
[	O
Significance	O
of	O
revision	O
of	O
the	O
occupational	O
illness	O
legislation	O
for	O
evaluating	O
intervertebral	SYMP
disk	SYMP
damage	SYMP
]	O
Serum	O
urate	O
during	O
bouts	O
of	O
acute	SYMP
gouty	SYMP
arthritis	SYMP
.	O
[	O
Isolated	O
axial	O
lateral	O
pulse	O
as	O
a	O
sign	O
of	O
latero-bulbar	SYMP
ischemia	SYMP
:	O
clinical	O
topographic	O
correlation	O
]	O
Microalbuminuria	SYMP
is	O
positively	O
associated	O
with	O
usual	O
dietary	O
saturated	O
fat	O
intake	O
and	O
negatively	O
associated	O
with	O
usual	O
dietary	O
protein	O
intake	O
in	O
people	O
with	O
insulin-dependent	SYMP
diabetes	SYMP
mellitus	SYMP
.	O
YES	O
Purification	O
and	O
characterization	O
of	O
an	O
acetyl	O
xylan	O
esterase	O
from	O
Bacillus	O
pumilus	O
.	O
The	O
Stresst'er	O
ergometer	O
as	O
an	O
alternative	O
to	O
treadmill	O
testing	O
in	O
patients	O
with	O
claudication	SYMP
.	O
Renal	SYMP
trauma	SYMP
and	O
the	O
risk	O
of	O
long-term	O
complications	O
in	O
shock	SYMP
wave	SYMP
lithotripsy	SYMP
.	O
Current	O
management	O
of	O
corneal	SYMP
abrasions	SYMP
:	O
evidence	O
based	O
practice	O
?	O
[	O
Placebo	O
in	O
drug	O
clinical	O
trials	O
]	O
Chromosome	O
22qII	O
deletions	O
.	O
An	O
under-recognised	O
cause	O
of	O
idiopathic	SYMP
learning	SYMP
disability	SYMP
.	O
Serial	O
magnetic	O
resonance	O
imaging	O
findings	O
for	O
a	O
spontaneously	O
resolving	O
spinal	SYMP
subdural	SYMP
hematoma	SYMP
:	O
case	O
report	O
.	O
A	O
simple	O
technique	O
for	O
correction	O
of	O
mucosal	SYMP
irregularities	SYMP
of	SYMP
the	SYMP
lip	SYMP
.	O
Cancer	SYMP
risk	O
in	O
the	O
rubber	O
industry	O
:	O
a	O
review	O
of	O
the	O
recent	O
epidemiological	O
evidence	O
.	O
HIV	O
treatment	O
strategies	O
:	O
planning	O
for	O
the	O
long	O
term	O
.	O
[	O
The	O
project	O
of	O
a	O
national	O
control	O
program	O
for	O
tuberculosis	SYMP
in	O
Spain	O
]	O
Decrease	O
in	O
antibiotic	O
susceptibility	O
or	O
increase	O
in	O
resistance	O
?	O
Helicobacter	O
pylori	O
and	O
abdominal	O
symptoms	O
:	O
a	O
population-based	O
study	O
among	O
preschool	O
children	O
in	O
southern	O
Germany	O
.	O
Have	O
we	O
treated	O
AIDS	SYMP
too	O
well	O
?	O
Rationing	O
and	O
the	O
future	O
of	O
AIDS	O
exceptionalism	O
.	O
[	O
Recommendations	O
on	O
antiretroviral	SYMP
treatment	SYMP
.	O
The	O
AIDS	O
Study	O
Group	O
of	O
the	O
Spanish	O
Society	O
of	O
Infectious	O
Diseases	O
and	O
Clinical	O
Microbiology	O
]	O
Requirements	O
for	O
training	O
to	O
ensure	O
competence	O
of	O
endoscopists	O
performing	O
invasive	O
procedures	O
in	O
children	O
.	O
Safe	O
motherhood	O
:	O
can	O
we	O
make	O
a	O
difference	O
?	O
Lumbar	SYMP
spine	SYMP
stenosis	SYMP
:	O
a	O
common	O
cause	O
of	O
back	O
and	O
leg	O
pain	SYMP
.	O
Myoepithelial	SYMP
carcinoma	SYMP
with	O
predominance	O
of	O
plasmacytoid	O
cells	O
arising	O
in	O
a	O
pleomorphic	SYMP
adenoma	SYMP
of	O
the	O
parotid	O
gland	O
.	O
Lonomia	O
obliqua	O
caterpillar	O
spicules	O
trigger	O
human	O
blood	O
coagulation	O
via	O
activation	O
of	O
factor	O
X	O
and	O
prothrombin	O
.	O
Doing	O
everything	O
.	O
Successful	O
replantation	O
of	O
an	O
amputated	O
tongue	O
.	O
Morbidity	O
and	O
healthcare	O
utilisation	O
of	O
children	O
in	O
households	O
with	O
one	O
adult	O
:	O
comparative	O
observational	O
study	O
.	O
A	O
novel	O
frameshift	O
mutation	O
840delA	O
and	O
a	O
novel	O
polymorphism	O
D203A	O
in	O
the	O
steroidogenic	O
acute	O
regulatory	O
protein	O
gene	O
in	O
a	O
Japanese	O
patient	O
with	O
congenital	SYMP
lipoid	SYMP
adrenal	SYMP
hyperplasia	SYMP
.	O
Mutations	O
in	O
brief	O
no	O
.	O
117	O
.	O
Online	O
.	O
Identification	O
of	O
five	O
new	O
mutations	O
and	O
three	O
novel	O
polymorphisms	O
in	O
the	O
muscle	O
chloride	O
channel	O
gene	O
(	O
CLCN1	O
)	O
in	O
20	O
Italian	O
patients	O
with	O
dominant	O
and	O
recessive	O
myotonia	SYMP
congenita	SYMP
.	O
Mutations	O
in	O
brief	O
no	O
.	O
118	O
.	O
Online	O
.	O
Identification	O
of	O
a	O
large	O
insertion	O
and	O
two	O
novel	O
point	O
mutations	O
(	O
3671del8	O
and	O
S1221X	O
)	O
in	O
tuberous	SYMP
sclerosis	SYMP
complex	SYMP
(	SYMP
TSC	SYMP
)	SYMP
patients	O
.	O
Mutations	O
in	O
brief	O
no	O
.	O
119	O
.	O
Online	O
.	O
Mutational	O
analysis	O
of	O
the	O
cystathionine	O
beta-synthase	O
gene	O
:	O
a	O
splicing	O
mutation	O
,	O
two	O
missense	O
mutations	O
and	O
an	O
insertion	O
in	O
patients	O
with	O
homocystinuria	SYMP
.	O
Mutations	O
in	O
brief	O
no	O
.	O
120	O
.	O
Online	O
.	O
Analysis	O
of	O
five	O
mutations	O
in	O
20	O
mucopolysaccharidois	SYMP
type	O
1	O
patients	O
:	O
high	O
prevalence	O
of	O
the	O
W402X	O
mutation	O
.	O
Mutations	O
in	O
brief	O
no	O
.	O
121	O
.	O
Online	O
.	O
A	O
novel	O
missense	O
mutation	O
Ile538Val	O
in	O
the	O
fibroblast	O
growth	O
factor	O
receptor	O
3	O
in	O
hypochondroplasia	SYMP
.	O
Mutations	O
in	O
brief	O
no	O
.	O
122	O
.	O
Online	O
.	O
Detection	O
of	O
four	O
novel	O
mutations	O
in	O
the	O
iduronate-2-sulfatase	O
gene	O
.	O
Mutations	O
in	O
brief	O
no	O
.	O
123	O
.	O
Online	O
.	O
Polymorphisms	O
in	O
the	O
coding	O
exons	O
of	O
the	O
human	O
luteinizing	O
hormone	O
receptor	O
gene	O
.	O
Mutations	O
in	O
brief	O
no	O
.	O
124	O
.	O
Online	O
.	O
Independent	O
occurrence	O
of	O
the	O
novel	O
Arg2163	O
to	O
His	O
mutation	O
in	O
the	O
factor	O
VIII	O
gene	O
in	O
three	O
unrelated	O
families	O
with	O
haemophila	SYMP
A	SYMP
with	O
different	O
phenotypes	O
.	O
Mutations	O
in	O
brief	O
no	O
.	O
126	O
.	O
Online	O
.	O
Are	O
Japanese	O
researchers	O
exploiting	O
Thai	O
HIV	O
patients	O
?	O
Underutilization	O
of	O
aspirin	SYMP
in	O
older	O
patients	O
with	O
prior	SYMP
myocardial	SYMP
infarction	SYMP
at	O
the	O
time	O
of	O
admission	O
to	O
a	O
nursing	O
home	O
.	O
Distinguishing	O
silent	SYMP
lacunar	SYMP
infarction	SYMP
from	O
enlarged	SYMP
Virchow-Robin	SYMP
spaces	SYMP
:	O
a	O
magnetic	O
resonance	O
imaging	O
and	O
pathological	O
study	O
.	O
Correlation	O
is	O
not	O
causation	O
.	O
Inhalation	O
of	O
ammonium	O
nitrate	O
fuel	O
oil	O
explosive	O
(	O
ANFO	O
)	O
Management	O
of	O
polycythaemia	SYMP
in	O
adults	O
with	O
cyanotic	SYMP
congenital	SYMP
heart	SYMP
disease	SYMP
.	O
Bolstering	O
Sisyphus	O
.	O
Use	O
of	O
public	O
performance	O
reports	O
:	O
a	O
survey	O
of	O
patients	O
undergoing	O
cardiac	SYMP
surgery	SYMP
.	O
Role	O
of	O
a	O
p53	O
polymorphism	O
in	O
the	O
development	O
of	O
human	SYMP
papillomavirus-associated	SYMP
cancer	SYMP
.	O
The	O
use	O
of	O
nurses	O
in	O
alternative	O
dispute	O
resolution	O
.	O
Re	O
:	O
Friday	O
afternoon	O
pulmonary	SYMP
arteriography	SYMP
(	SYMP
FAPA	SYMP
)	SYMP
:	O
are	O
Fridays	O
good	O
for	O
your	O
health	O
?	O
Hormone	SYMP
replacement	SYMP
therapy	SYMP
and	O
breast	SYMP
cancer	SYMP
.	O
Physician	O
heal	O
thyself	O
:	O
are	O
antibiotics	SYMP
the	O
cure	O
or	O
the	O
disease	O
?	O
Primary	SYMP
biliary	SYMP
cirrhosis	SYMP
.	O
Polymorphism	O
in	O
promoter	O
region	O
of	O
inducible	O
nitric	O
oxide	O
synthase	O
gene	O
and	O
protection	O
against	O
malaria	SYMP
.	O
Ventilatory	O
responses	O
to	O
acute	O
and	O
sustained	O
hypoxia	O
during	O
isoflurane	O
anesthesia	O
.	O
Leprosy	SYMP
type	SYMP
1	SYMP
reaction	O
as	O
the	O
first	O
manifestation	O
of	O
borderline	O
lepromatous	SYMP
leprosy	SYMP
in	O
a	O
young	O
native	O
German	O
.	O
YES	O
Trisomy	O
10	O
in	O
leukemia	SYMP
.	O
Receptive	O
properties	O
of	O
primary	O
afferent	O
fibres	O
from	O
rabbit	O
pleura	O
,	O
in	O
vitro	O
.	O
Congenital	SYMP
anomalies	SYMP
of	SYMP
tracheobronchial	SYMP
branching	SYMP
patterns	SYMP
:	O
spiral	O
CT	O
aspects	O
in	O
adults	O
.	O
American	O
Heart	O
Association	O
urges	O
caution	O
on	O
new	O
diet	O
drug	O
.	O
Absence	O
of	O
renal	O
and	O
hepatic	O
toxicity	O
after	O
four	O
hours	O
of	O
1.25	O
minimum	O
alveolar	O
anesthetic	O
concentration	O
sevoflurane	O
anesthesia	O
in	O
volunteers	O
.	O
Linear	SYMP
lichen	SYMP
planopilaris	SYMP
of	O
the	O
face	O
.	O
Electrolyte	O
abnormalities	O
in	O
patients	O
with	O
chronic	SYMP
renal	SYMP
failure	SYMP
receiving	O
parenteral	O
nutrition	O
.	O
Risk	O
factors	O
for	O
hemiretinal	SYMP
vein	SYMP
occlusion	SYMP
:	O
comparison	O
with	O
risk	O
factors	O
for	O
central	SYMP
and	SYMP
branch	SYMP
retinal	SYMP
vein	SYMP
occlusion	SYMP
:	O
the	O
eye	O
disease	O
case-control	O
study	O
.	O
The	O
psychological	O
profiles	O
of	O
patients	O
with	O
whiplash-associated	SYMP
headache	SYMP
.	O
TO_SEE	O
Bifid	O
T	O
waves	O
induced	O
by	O
isoprenaline	SYMP
in	O
a	O
patient	O
with	O
Brugada	SYMP
syndrome	SYMP
.	O
[	O
Quo	O
vadis	O
``	O
suprema	O
lex	O
''	O
?	O
]	O
Death	O
in	O
springtime	O
.	O
YES	O
Relatives	O
in	O
the	O
resuscitation	O
room	O
:	O
their	O
point	O
of	O
view	O
.	O
Large	SYMP
airway	SYMP
disease	SYMP
associated	O
with	O
inflammatory	SYMP
bowel	SYMP
disease	SYMP
.	O
Autonomy	O
in	O
the	O
face	O
of	O
a	O
devastating	O
diagnosis	O
.	O
Advanced	O
practice	O
nursing	O
:	O
is	O
the	O
physician	O
's	O
assistant	O
an	O
accident	O
of	O
history	O
or	O
a	O
failure	O
to	O
act	O
?	O
Acute	SYMP
obstructive	SYMP
hydrocephalus	SYMP
complicating	O
bacterial	SYMP
meningitis	SYMP
in	O
childhood	O
.	O
Subcutaneous	O
autologous	O
ovarian	O
transplantation	O
in	O
Wistar	O
rats	O
maintains	O
hormone	O
secretion	O
.	O
Teaching	O
irritable	SYMP
bowel	SYMP
syndrome	SYMP
patients	O
to	O
care	O
for	O
themselves	O
.	O
Nonanesthetic	O
volatile	O
drugs	O
obey	O
the	O
Meyer-Overton	O
correlation	O
in	O
two	O
molecular	O
protein	O
site	O
models	O
.	O
YES	O
Directly	O
observed	O
therapy	O
and	O
treatment	O
completion	O
for	O
tuberculosis	SYMP
in	O
the	O
United	O
States	O
:	O
is	O
universal	O
supervised	O
therapy	O
necessary	O
?	O
Investigation	O
of	O
antibiotic	SYMP
prophylaxis	SYMP
usage	O
for	O
vascular	O
and	O
nonvascular	O
interventional	O
procedures	O
.	O
Effect	O
of	O
protein	O
kinase	O
C	O
inhibitors	O
on	O
cardioprotection	O
by	O
ischemic	O
preconditioning	O
depends	O
on	O
the	O
number	O
of	O
preconditioning	O
episodes	O
.	O
How	O
do	O
you	O
treat	O
refractory	SYMP
pouchitis	SYMP
and	O
when	O
do	O
you	O
decide	O
to	O
remove	O
the	O
pouch	O
?	O
Filter	O
paper	O
blood	O
spot	O
assay	O
of	O
human	O
insulin-like	O
growth	O
factor	O
I	O
(	O
IGF-I	O
)	O
and	O
IGF-binding	O
protein-3	O
and	O
preliminary	O
application	O
in	O
the	O
evaluation	O
of	O
growth	O
hormone	O
status	O
.	O
Effect	O
of	O
iodixanol	SYMP
on	O
renal	O
function	O
immediately	O
after	O
abdominal	SYMP
angiography	SYMP
.	O
Clinical	O
comparison	O
with	O
iomeprol	SYMP
and	O
ioxaglate	SYMP
.	O
A	O
new	O
modified	O
technique	O
for	O
harvest	O
of	O
calcaneal	O
bone	O
grafts	O
in	O
surgery	SYMP
on	O
the	O
foot	O
and	O
ankle	O
.	O
Is	O
prevaccination	O
screening	O
for	O
hepatitis	SYMP
B	SYMP
among	O
sexually	O
active	O
adolescents	O
cost-effective	O
?	O
Epilepsy	SYMP
--	O
a	O
guide	O
to	O
medical	O
treatment	O
.	O
1	O
:	O
Antiepileptic	SYMP
drugs	SYMP
.	O
Adolescent	O
pregnancy	O
and	O
sexual	O
abuse	O
.	O
YES	O
A	O
multidimensional	O
study	O
of	O
preference	O
judgements	O
for	O
excerpts	O
of	O
music	O
.	O
Extending	O
the	O
benefits	O
of	O
breast	SYMP
cancer	SYMP
screening	O
.	O
Still	O
hard	O
to	O
know	O
how	O
large	O
the	O
benefits	O
will	O
really	O
be	O
.	O
[	O
Rhabdomyolysis	SYMP
and	O
carbon	SYMP
monoxide	SYMP
poisoning	SYMP
]	O
Effect	O
of	O
dental	SYMP
treatment	SYMP
on	O
the	O
lung	O
function	O
of	O
children	O
with	O
asthma	SYMP
.	O
